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Summary
The circadian clock is a tightly regulated mechanism that has evolved in most organ-
isms to enable them to anticipate daily reoccurring changes in the environment. Ex-
pression analysis in mouse suggests that about 10% of the mammalian transcriptome
may be under circadian control, however the overlap between different tissues is very
small [1]. Mechanisms determining this cell type specificity of clock controlled genes
are not yet understood. The human osteosarcoma cell line U2OS expresses a func-
tional circadian clock and has been used in many circadian studies [2, 3, 4], yet, except
for components of the core clock machinery, no genes have been found to be rhyth-
mically expressed in this cell line in a microarray analysis [3] whereas about 3000
rhythmic transcripts have been identified in mouse liver [3, 5, 6].
This work shows ChIP-sequencing data of BMAL1, CLOCK, and CRY1 that indicates
that the circadian transcription regulators bind in sequence-specific manner to several
thousand sites in the genome of U2OS, comparable to the number found in mouse
liver [5]. However, time course microarray experiments carried out to verify function-
ality of these sites, found only 58 rhythmic genes harboring a binding site, suggesting
a high amount of opportunistic binding that cannot be linked to transcription. Even
most genes with high-scoring binding sites in their promoter were apparently arrhyth-
mic. U2OS cell lines stably expressing luciferase reporter constructs under control of
representative promoters were generated and revealed that BMAL1 and CLOCK func-
tionally act on these, but rhythmic expression appears to be superimposed by a high
basal transcription. The data indicates that high amplitude transcription rhythms are
masked by constitutive transcription that overwrites the rhythmic contribution of the cir-
cadian clock, resulting in apparent arrhythmicity due to low amplitude oscillations. This
work suggests that the cell-type specific circadian transcriptome is not determined on
the level of BMAL1-CLOCK binding and rhythmic activation of transcription by these
circadian regulators, but rather by the cell-type specific ratio of circadian versus gene-
specific or general transcription regulators.

Zusammenfassung
Die zirkadiane Uhr ist ein streng regulierter Mechanismus, der sich in den meisten
Organismen entwickelt hat um täglich wiederkehrende Veränderungen in der Umge-
bung zu antizipieren. Analysen des Maus Transkriptoms deuten darauf hin, dass
ungefähr 10% der in Säugetieren exprimierten Gene unter der Kontrolle der zirkadi-
anen Uhr stehen, jedoch scheint die Überlappung dieser in verschiedenen Geweben
sehr klein zu sein [1]. Mechanismen, wie es zu dieser Zelltyp-Spezifität von durch die
Uhr regulierten Genen kommt, sind bislang unverstanden. Die humane Osteosarkoma
Zelllinie U2OS besitzt eine funktionelle zirkadiane Uhr und wurde in vielen chronobio-
logischen Studien verwendet [2, 3, 4], dennoch wurden in einer Microarray-Analyse,
außer den Hauptkomponenten der zirkadianen Uhr, keine rhythmischen Gene in dieser
Zelllinie gefunden [3], während in der Leber von Mäusen ungefähr 3000 rhythmische
Transkripte identifiziert wurden [3, 6, 5].
Diese Arbeit zeigt ChIP-sequencing Daten von BMAL1, CLOCK und CRY1, die
darauf hindeuten, dass die zirkadianen Transkriptionsregulatoren sequenz-spezifisch
an mehrere tausend Stellen im Genom von U2OS binden, einer Zahl vergleichbar
mit der in Maus Leber [5]. Zwei Zeitreihen wurden auf Microarrays getestet um die
Funktionalität der Bindungsstellen zu verifizieren, jedoch wurden nur 58 rhythmische
Gene mit Bindungsstellen gefunden, was darauf schließen lässt, dass der Großteil der
Bindungsstellen opportunistisch ist und nicht mit rhythmischer Transkription in Verbin-
dung gebracht werden kann. Sogar Gene mit besonders guten Bindungsstellen in
ihrem Promotor erscheinen arrhythmisch. U2OS Zelllinien wurden generiert, bei denen
Luziferase-Reporter Konstrukte unter Kontrolle von repräsentativen Promotoren stabil
integriert wurden. Diese Zellen zeigen, dass BMAL1 und CLOCK zwar auf diese Pro-
motoren wirken, eine rhythmische Expression aber gleichzeitig überlagert wird durch
eine hohe Basal-Transkription. Die Daten deuten darauf hin, dass Transkriptionsrhyth-
men mit hoher Amplitude durch konstitutive Expression maskiert werden, die die rhyth-
mische Komponente der zirkadianen Uhr überschreibt, so dass eine scheinbare Ar-
rhythmizität, bedingt durch Oszillationen mit sehr niedriger Amplitude, entsteht. Diese
Arbeit schlägt vor, dass das Zelltyp-spezifische zirkadiane Transkriptom nicht auf der
Ebene von BMAL1-CLOCK Bindung und rhythmischer Aktivierung der Transkription
bestimmt wird, sondern durch ein Zelltyp-spezifisches Verhältnis von zirkadianen zu
genspezifischen oder allgemeinen Transkriptionsregulatoren.
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1. Introduction
1.1. Circadian clocks - an overview
Circadian clocks (Latin "circa diem" = about a day) are endogenous devices that have
evolved in all kingdoms of life in order to anticipate the alternating challenges of day
and night imposed on all living beings by the rotation of the earth. Self sustained
molecular clocks are found on the level of single cells not only in unicellular organisms
but also in multicellular organisms [7]. The circadian clock is not essential for sur-
vival but it conveys an evolutionary advantage to the organism. In Cyanobacteria and
lower eukaryotes like the filamentous fungus Neurospora crassa, the clock organizes
metabolism and growth in a temporal manner. In higher eukaryotes the clock regulates
rhythmic behavior in addition to physiological and metabolic rhythms in the course of
the day.
There are three main properties of all circadian clocks: First, they are endogenous
mechanisms, which means that the core of the clock lies in an internal oscillator en-
coded by the genome. Second, circadian clocks are self-sustained, therefore, even in
the absence of environmental stimuli, the clock remains functional and influences the
expression of genes in a rhythmic fashion. Third, they are temperature-compensated.
Although the molecular oscillator depends on a series of chemical reactions, these
are balanced in such a way, that the period retains approximately the same length
even when the temperature changes. This is most important in poikilotherm organisms
whose internal temperature varies with the external temperature.
The circadian clock is organized in three parts: An input pathway, a feedback loop,
and an output pathway (Fig. 1.1). At the core of the molecular circadian clock in all
eukaryotes there is a set of interconnected transcriptional and translational feedback
loops that establish a rhythmic response with a period of about 24 hours. Briefly, a
positive regulator activates transcription of a gene that negatively feedbacks on its own
expression. Over time the negative regulator accumulates, resulting in repression of its
own transcription. Protein turnover in turn decreases levels of the negative regulator,
thus activating its expression. The kinetics of this feedback loop are delayed via sev-
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Figure 1.1.: Scheme of the general mechanism of the circadian clock. A Zeitgeber
(Input), such as light or temperature, conveys timing information to the
endogenous molecular clock. At the core of the feedback loop a tran-
scriptional activator (+) leads to expression of its own negative regulator
(-). Transcription and translation (TS/TL) delay this process such that the
feedback loop takes about 24 hours. Other genes that are under control
of the activator influence diverse functions in the cell (Output).
eral mechanisms to generate a period that approximately reflects the external day of 24
hours. This is achieved in part on a post-transcriptional level by influencing RNA stabil-
ity and splicing, as well as on posttranslational levels via acetylation, phosphorylation,
ubiquitination, and sumoylation [8, 9, 10].
Several input pathways convey timing information to the core oscillator and synchro-
nize it with the environment. Entrainment, i.e. adjustment of the clock to a specific
rhythm, for example of light, temperature or nutrients, can reset the clock. Different
mechanisms have evolved to sense light, which is one of the strongest cues. Unicellu-
lar organisms have developed light-sensitive elements in one or more components of
the molecular clock. Some multicellular organisms like zebrafish and Drosophila can
detect illumination via specific light receptors in each cell of the body. Most vertebrates
have one or a small number of specialized cells, which sense light, and relay this tim-
ing information to another specialized structure in the brain, the so called master-clock,
which then entrains all other clocks of the body, the peripheral clocks, to the exogenous
timing regime. When traveling to a different timezone, for instance, the light of the sun
phase-shifts our rhythm from the internal, endogenous time, to the exogenous, local
time, which is why we experience the so called jet lag
The core oscillator activates clock-controlled genes that generate the output of the
circadian clock by rhythmically modulating many cellular functions, for example via
control of key enzymes in metabolic pathways. The level of clock-controlled genes
oscillate throughout the day resulting in abundance rhythms of the encoded protein.
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In some cases these genes are found to feedback on the clock itself, generating a
further loop in the circadian system. This feedback can transmit information about the
metabolical state to the core oscillator and lead to more robustness. A major goal in
the field of chronobiology is to elucidate which genes are controlled by the circadian
clock and how their expression influences other pathways and the clock itself. In higher
eukaryotes this is a challenging task, because studies have shown, that there is only
little overlap between clock-controlled genes in different cell types and tissues [1] and
the mechanisms that convey this tissue-specificity are yet unknown.
1.2. The circadian clock in different organisms
The circadian clock can be found in almost all branches of life. In this chapter a general
overview shall be given over input and output of the circadian clock, as well as the key
players of the core-loop. Moreover, common methods to analyze the rhythm in these
organisms will be described briefly. A detailed description of the circadian clock in
mammals, will be given in the following chapter.
1.2.1. Invertebrates
The existence of a circadian clock has first been described in plants. Later, the first
successful studies in elucidating the molecular basics of the circadian clock have been
performed in invertebrates, namely cyanobacteria, the filamentous fungus Neurospora
crassa and the fruit fly Drosophila melanogaster. Nowadays improved genetic tools en-
able us to study the molecular basis of the clock in vertebrates as well. Nevertheless,
the machinery underlying the circadian clock in invertebrates remains the best under-
stood, and therefore gives interesting insights into the even more complex mechanisms
in higher organisms.
1.2.1.1. Cyanobacteria (Synechococcus elongatus)
Cyanobacteria are the simplest and the most ancient forms of life that have been
found to possess a circadian clock. As phototrophs, the biochemistry and physiol-
ogy of cyanobacteria must be attuned to the availability of energy from light. To date,
cyanobacteria remain the only prokaryotes shown to possess a true circadian clock.
Synechococcus elongatus, a freshwater unicellular cyanobacterium, has been used
extensively for circadian studies because of the wide array of genetic tools available for
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Figure 1.2.: Schematic overview of KaiC phosphorylation/dephosphorylation. The
KaiC phosphorylation cycle consists of four sequential reactions. Dur-
ing steps 1 and 2, KaiC exhibits autokinase activity and during steps 3
and 4, KaiC serves as an autophosphatase. Phosphorylation of S431
creates the double-phosphorylated form (pS/pT) and switches KaiC from
an autokinase to an autophosphatase, whereas dephosphorylation of
S431 leads to the completely dephosphorylated form (S/T), switching
KaiC from a phosphatase to a kinase. Phosphorylation of T432 is stim-
ulated by KaiA (step 1) and activates phosphorylation of S431 (step 2).
Likewise, dephosphorylation of T432 (step 3) activates dephosphoryla-
tion of S431 (step 4) upon which KaiB binds to KaiC, inactivating KaiA.
Figure and Legend adapted from Nishiwaki et al. [11].
this organism. Its core oscillator is made up of three proteins: KaiA, KaiB, and KaiC [12]
(Kai means "cycle" in Japanese). Both, the abundance and the phosphorylation states,
of KaiC cycle in vivo. In vitro, the three core proteins and ATP are sufficient to produce
circadian oscillation in KaiC phosphorylation with a period of about a day [13]. As op-
posed to other clocks, where the negative regulator is degraded, this system does not
require protein synthesis for the subsequent circadian cycle. Rhythmic phosphoryla-
tion occurs, because KaiC switches from autokinase to autophosphatase activity upon
double phosphorylation. Stimulation of KaiC by KaiA results in autophosphorylation of
threonine 432 of KaiC. KaiC subsequently autophosphorylates serine 431. KaiC now
has increased dephosphorylation activity and first removes a phosphate at T432 upon
which KaiB binds to KaiC. This traps and inactivates KaiA, thus allowing further KaiC
dephosphorylation [11] (Fig. 1.2).
Various studies suggest that there is no specific interaction of clock proteins with
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the kaiBC promoter in prokaryotes, but rather that KaiC affects all gene promoters
in a common genome-wide manner by rhythmically modifying chromosome topology
[14, 15, 16]. Furthermore the S.elongatus circadian clock has been found to gate cell
division, whereas the cell cycle has no effect on the circadian clock [17].
Cyanobacteria sense light via several pathways that inform the cell about its redox
state, which correlates with light in a photosynthetic organism, and thereby keep the
circadian clock synchronized with the environment [18, 19]. Recent experiments even
suggest that KaiA itself can bind the oxidized form of quinone and that its aggregation
upon such binding negatively affects KaiC phosphorylation [20].
1.2.1.2. Plants
The possibility for an intrinsic circadian clock has first been discussed in plants. In
1729, the scientist Jean-Jacques de Marain realized that rhythmic petal movement of
Mimosa pudica was not simply a response to the sun, but persisted even in the absence
of sunlight [21]. In the following centuries the intrinsic circadian clock remained a matter
of debate, but is now accepted as a fact by scientists.
In Arabidopsis thaliana the circadian clock regulates numerous biological processes,
such as rhythmic leaf movement and petal opening [22], hormone biosynthesis and re-
sponse [23], water uptake [24], and even pathogen response [25]. Plants with a clock
period that matches the environment contain more chlorophyll, fix more carbon, grow
faster, and survive better than plants with circadian periods differing from that of their
environment, which shows that the circadian clock confers a photosynthetic advantage
to them [26]. Furthermore, plants are able to measure the environmental photoperiod,
in order to permit flowering to occur only during the correct season [27]. Circadian reg-
ulation of transcription affects roughly one third of the genes in Arabidopsis [28, 23, 29].
The circadian clock in plants is reset by light, which is sensed through phytochromes
(red and far-red photoreceptors), as well as cryptochromes [30, 31] and the proteins of
the ZEITLUPE (ZTL) family (blue-light receptors) [32]. By controlling their expression
the circadian clock is able to modulate susceptibility for light entrainment cues [33].
The plant clock is very complex and made up of several interconnected feedback
loops with various key players for each time of the day. The main components will
be briefly explained here. In the so called three-loop model (Fig. 1.3) there are a
morning loop and an evening loop which interlock with the central core loop [34]. The
main players of the central loop are LHY (LATE AND ELONGATED HYPOCOTYL) and
CCA1 (CIRCADIAN CLOCK ASSOCIATES 1) which are expressed in the morning and
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repress transcription of TOC1 (TIME OF CAB EXPRESSION 1), confining its expres-
sion to dusk. Conversely, TOC1, promotes the expression of CCA1 and LHY. In the
morning loop, PRR (PSEUDO RESPONSE REGULATOR) 9, PRR7, and PRR5 asso-
ciate sequentially with the promoter of LHY and CCA1 to repress their transcription
and counteract the activating function of TOC1. An evening loop is proposed between
an unknown light-inducible component Y and TOC1. Partial Y function was assigned
to the evening gene GI (GIGANTEA) and is mediated by its physical interaction with
ZTL, an F-box protein that facilitates ubiquitination and subsequent degradation of both
TOC1 and PRR5 [35]. Additional loops connect ELF3 (EARLY FLOWERING 3)-ELF4
and LUX with LHY-CCA1 and PPR9. Recently, rhythmic histone-acetylation changes
have been found to be important for clock transcriptional regulation as well [36, 37]
Figure 1.3.: Circadian feedback loops in plants. Circadian clock components are con-
nected by several feedback loops. Central loop (black), morning loop
(orange), and evening loop (light blue) conform to the three-loop model.
Additional loops connect ELF3-ELF4 and LUX with LHY and CCA1 (pink)
and with PRR9 (green). Protein-protein interactions between the evening
loop components, ZTL and PRR5, are indicated with dashed lines. The
model is further explained in the text. Figure and Legend from Herrero
and Davis [35].
Apart from its daily role, the circadian clock also fulfills roles in overwintering of
perennial plants that live for more than two years through initiation of growth cessa-
tion and dormancy [38] and contribution to cold hardiness [39, 40]. In trees, as in
Arabidopsis, cold tolerance is correlated with CCA1 and LHY expression [40]. Current
studies are aiming at establishing more precisely how cold regulates CCA1 and LHY
expression to provide new tools for breeding of plants that are better adapted to local
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climates and for broadening the latitudinal range of crops.
1.2.1.3. Fungi (Neurospora crassa)
Neurospora crassa is a filamentous fungus that is characteristically found as first set-
tlers after forest fires on dead organic material. It commonly grows as a mycelium
of haploid hyphae that contain multiple nuclei. Vegetative growth is interspersed by
formation of bright orange aerial hyphae that segment into the asexual spores called
conidia. This process is controlled by the circadian clock, making rhythmic conidiation
of Neurospora an easy way for following the circadian rhythm of the organism. If ap-
plied to one end of a glass tube with an agar-bottom (so called race tubes) Neurospora
band-strains grow in alternating patterns of vegetative hyphae and conidia along the
tube. This enables scientists to study the effect of mutations on period and phase of
the circadian clock. This simple way of analyzing the clock contributed significantly to
the current understanding of the circadian clock.
The key players of the circadian clock in Neurospora are the transcription factors WC-
1 (White-Collar 1) and WC-2 (White-Collar 2) and their negative regulator FRQ (Fre-
quency). WC-1 and WC-1 form a dimer, WCC, the White-Collar-Complex, which drives
directly and indirectly rhythmic expression of clock-controlled genes [41]. In the morn-
ing the WCC is located in the nucleus where it activates transcription of frq and other
target genes. During the course of the day FRQ protein is produced, dimerizes and as-
sembles with FRH (FRQ-interacting helicase) and CK1a (Casein kinase 1a) into a high
molecular mass complex, which is transported into the nucleus. Progressive phos-
phorylation on up to 113 phosphorylation sites of FRQ changes its three-dimensional
conformation, exposes a PEST (proline, glutamic acid, serine, threonine) sequence
and results in its degradation [42]. In the nucleus FRQ interacts with the WCC and
mediates its phosphorylation via CK1a [43, 44]. The transcriptionally active unphos-
phorylated WCC is unstable [45], whereas phosphorylated WCC is inactive but stable
and accumulates in the cytosol, where it is dephosphorylated by Protein-Phosphatase
2A, which allows a new cycle to begin [45].
Extensive studies on light response and -adaptation have been carried out in Neu-
rospora crassa. The filamentous fungus has developed a system that does not react
to disturbing illumination cues during the night, such as the moon, and at the same
time remains able to sense very low levels of light if necessary. The response to light
is mediated by the WCC and the clock-controlled protein VVD (Vivid). Both, VVD
and WCC, contain a LOV (Light, Oxygen, Voltage) domain which enables dimerization
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Figure 1.4.: Molecular mechanism of the circadian clock in Neurospora crassa as
described in the text. Figure from Schafmeier et al. [45].
upon illumination. Light-induced homodimerization of the WCC activates its function
as a transcription factor, but when VVD accumulates during the day it inactivates the
WCC by competitive formation of WCC-VVD heterodimers. During the night, remaining
protein levels of VVD suppress responses to low light cues [46].
ChIP-sequencing of the targets of WCC in Neurospora lead to discovery of many
new clock-controlled genes, a substantial portion of which are transcription factors
themselves. Among these, CSP1 (Conidial Separation 1), a transcriptional repressor,
has been found to regulate activation of its target genes in antiphase to the rhythm pro-
duced by the WCC [47]. It is a very good example of how a small set of clock-controlled
genes can control a larger set of genes in a rhythmic fashion on a genome-wide scale.
CSP1 modulates expression of the fatty acid desaturases, and thereby regulates lipid
homeostasis of Neurospora in the course of the day. During the night, when CSP1
repression is lifted, fatty acid desaturases are produced, leading to a higher proportion
of desaturated acids in the membranes, which makes the membranes more fluid - a
reaction that counteracts the increased rigidity of membranes in the cold [47].
1.2.1.4. Fruit fly (Drosophila melanogaster)
The fruit fly Drosophila melanogaster provides an excellent model system for studying
the molecular and neurogenetic basis of circadian behavioral rhythms in higher eukary-
otes [48]. In 1971 the first clock gene, period, was found in Drosophila [49]. Many more
clock genes followed in the next decades and it turned out that period was conserved
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in mouse, zebrafish and humans [50, 51, 52, 53]. The simplicity of Drosophila’s neu-
ronal network organization in the brain makes it of special use in neurological studies
regarding the clock. A so called master clock" or "pacemaker" is located in the brain,
that controls behavioral rhythms and can be reset by light. About 150 clock cells per
brain hemisphere permit dissection of the function of single cells or cell clusters in the
brain [54].
The current model (see Figure 1.5) [54] predicts that the helix-loop-helix transcrip-
tion factors Clk (Clock) and Cyc (Cycle) bind as heterodimers to E-box sequences
(CACGTG) in the promoter regions of their target genes at midday, thereby activating
transcription of the genes per (period) and tim (timeless). Per appears to be the main
player in the negative feedback loop, whereas the function of Tim is mainly to protect
Per from phosphorylation by Dbt (Double-Time) Kinase and subsequent ubiquitination
by Slimb leading to proteasomal degradation. This can be counteracted by PP2A (Pro-
tein phosphatase 2 A) as well. Mediated by CK2 (Casein Kinase 2) the Per-Dbt-Tim
complex translocates into the nucleus, where it binds to Clk/Cyc dimers causing hy-
perphosphorylation of Clk, which prevents the Clk/Cyc dimer from binding to the DNA.
As in the clock of Neurospora crassa, the negative regulators cause phosphorylation
of the transcriptional activators leading to their inactivation. Recently, another clock
controlled gene encoding for the basic helix-loop-helix orange-domain putative tran-
scription factor Cwo (clockwork orange) has also been found to repress transcription
of Clk target genes [55]. A second feedback loop interlocks with the first by regulating
the transcription of clk, which is transcribed in a reciprocal way, called "in antiphase",
to tim/per. Clc/Cyc also activate transcription of vrille and pdp1. Both proteins bind to
so called V/P boxes in the promoter region of clk. While Vrille is inhibiting expression
of clk, Pdp1 activates clk transcription.
The 150 neurons per hemisphere of the Drosophila brain that make up the mas-
ter clock, are divided into seven major groups, named after their anatomical position.
There are three dorsal neuronal groups (DN1-3), 4 lateral neuronal groups (LNd, I-
LNv, LPN, s-LNv), as well as an additional set of a few hundred glia cells [56]. DNs
and LPNs seem to be primarily temperature-entrainable, whereas the LNs seem to be
preferentially entrainable by light [57].
Drosophila has three different photoreceptive organs, the complex eyes, the ocelli,
and the Hofbauer-Buchner eyelet, which all contain different opsin-based photopig-
ments. Two or more additional photopigments exist, that are not restricted to these
photoreceptive organs. At least three molecular pathways in Drosophila respond to
illumination and only when all three input routes are absent, is the circadian system
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CT 12 - 18
Figure 1.5.: Molecular mechanisms of the Drosophila circadian clock. For details see
main text. The figure displays a neuronal clock cell at different times
of the day. The neuron is compartmented into nucleus and cytoplasm.
Each quarter of the cell roughly represents six hours of the circadian
day, while the right side (0 - 12) is in light and the left side (12 - 24)
in darkness. P indicates phosphate/phosphorylation, the accompanying
arrow indicates transfer of phosphate. Dashed arrows or dashed pro-
teins symbols indicate proteasomal degradation. Angular arrows display
transcription, sinuous lines mark mRNAs. Normal arrows indicate move-
ment from the cytoplasm to the nucleus. Figure and Legend adapted
from Peschel & Förster [54].
unable to react on light [58]. One pathway for synchronization to light occurs via the
blue-light photopigment Cry that is expressed in some specialized DN1 cells and in the
compound eyes of the fly [59]. Illumination probably induces a conformational change
in Cry, enabling it to bind Tim and thus triggering its degradation. As a consequence of
the lack of Tim, Period becomes vulnerable to proteasomal degradation as well [54].
Drosophila was found to be a crepuscular insect, an insect that is mainly active at
dusk and at dawn. This activity pattern can be measured by putting individual animals
into small tubes and measuring the locomotor activity of the fly by a laser or a detector
at one end of the tube. The fact that Drosophila shows an activity peak in the morning
and another one in the evening is difficult to combine with the theory of one circadian
clock. Therefore it was proposed that Drosophila contains a set of two coupled oscil-
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lators, a morning oscillator that is accelerated by light, and an evening oscillator that is
slowed down by light [54]. This could enable Drosophila to adapt to different photope-
riods. The model of the two oscillators is still under debate in the Drosophila-field. A
recent Letter to Nature [60] is challenging many key laboratory-based assumptions by
studies that were carried out under natural conditions. Among other things, they found
that under high daytime temperatures Drosophila shows a third - afternoon - peak and
become rather diurnal than crepuscular.
1.2.2. Vertebrates
The molecular mechanism of the core clock among the various species of vertebrates
is relatively conserved and therefore the basics of this mechanism with some minor dif-
ferences apply to zebrafish, birds, and mammals alike and will be discussed together
with the mammalian clock in more detail in the next chapter. For this reason special
emphasis will be put onto the differences between the organisms in the following sec-
tion.
1.2.2.1. Zebrafish (Danio rerio)
The zebrafish represents a very useful model for studying key aspects of the vertebrate
circadian clock, such as the establishment of the molecular clock during embryogene-
sis and the light input pathway.
One of the characteristic features of the vertebrate in comparison to the inverte-
brate clock is the presence of additional copies of key clock genes. In the zebrafish a
genome duplication event during the evolution of the teleost lineage has lead to even
more additional copies [61]. Some of these have been lost during evolution, others
persist. The latter ones either have a redundant function or the multiple functions of
one original protein are now performed by several more specialized ones [62]. The
most impressive example for this can be found in the cryptochrome gene, which exists
once in Drosophila, twice in mammals, but with six copies in zebrafish, all of these with
diverse functions and expression patterns [63].
Remarkably, the zebrafish appears to be the only vertebrate, in which peripheral
clocks can be entrained by light, even in cell culture [64]. However, the nature of the pe-
ripheral photoreceptor remains elusive to date. Three possible candidates have been
proposed. Most likely one of the Cry homologs, Cry4, which shares closest sequence
similarity to Drosophila Cry, has the ability to act as a light sensor [63]. In Drosophila
Cry is known to play an important role in photoreception in the brain. Experimental
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data also suggests that zebrafish senses the redox state through hydrogen peroxide
production by a phototransducing flavin-containing oxidase [65], which would resem-
ble the light input sensing pathway of cyanobacteria. Moreover, extra retinal opsin-like
genes have been found in zebrafish, but so far no functional data has confirmed that
they indeed serve as photoreceptors [66].
A light responsive module, consisting of closely spaced E- and D-box elements has
been found in proximity to the transcription start site of per2 and is critical for its light-
driven rhythmic expression. The D box binding transcription factor, Tef (thyrotrope
embryonic factor), was shown to be a key player for mediating this in zebrafish [67].
Interestingly, the per2 promoter region is highly conserved and Tef is also expressed
among vertebrates, although other species like mouse and human lack directly light-
entrainable peripheral cells. It is proposed that during the course of evolution ancestral
light-responsive mechanisms may have been subverted to signals other than light [62].
There are two main methods how effects on the circadian clock are monitored in
zebrafish. Individual larvae can be placed in 24 well microtiter plates and then an
automated video analysis system documents swimming activity, which is diurnal in ze-
brafish. Locomotor activity in adult fish, however, is less robust than in larvae [68, 69].
Alternatively, the rhythmic release of melatonin from the pineal gland can be monitored.
Melatonin release is first detected around 24 hours post fertilization and therefore one
of the first measurable clock outputs during development [70, 71]. In addition, adult
pineal glands continue to rhythmically synthesize melatonin even in culture in a light
and clock-dependent manner [72]. Nowadays, luciferase-reporter gene activity under
control of a clock-regulated promoter is also used for studying the clock output [73].
This method is quite convenient in zebrafish, because embryos and larvae can be
screened alive in a 96 well microtiter plate, since they are completely transparent.
1.2.2.2. Birds
The circadian pacemaking system of birds comprises three major components: the
pineal gland, which rhythmically synthesizes and secretes melatonin, a specific hy-
pothalamic region, and the retinae of the eyes. These components work together to
produce the circadian output, but their relative contribution to overt rhythmicity appears
to differ between species. What is more, the system may change its properties even
within an individual, depending, for instance, on its state in the annual cycle or its photic
environment [74].
There are some important aspects that appear to function differently in birds. Most
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notably, birds possess extraoccular photoreceptors in the pineal gland and brain, pri-
marily within circumventricular structures that can be entrained directly to light-dark
cycles. Moreover, several specialized photopigments have been associated with clock
function, including pinopsin and melanopsin. Structural analyses of chick CRY2 pre-
dicts its photoreceptive capabilities [75]. Furthermore, there are several reports stating
that CRY1 and CRY2 levels respond to lighting conditions [76].
A very special characteristic of the circadian clock in birds is that it is necessary for
navigation and migration. Many experiments have shown that migrating birds use their
internal clock in conjunction with the position of the sun to determine their longitudinal
localization [77]. Retinal cryptochromes might further be involved in magnetoreception
[78]. Apart from navigation, recent work on the night-migratory blackheaded bunding
showed that long days induce the migratory phenotype, including body fattening and
Zugunruhe, as well as testis maturation, suggesting an effect of the circadian clock on
seasonal breeding [79] as well.
1.3. Circadian clocks in mammals
1.3.1. Overview
The circadian clock among mammals is quite conserved. The master clock is located in
a substructure of the hypothalamus just above the optic chiasm and is hence called the
suprachiasmatic nucleus (SCN). The SCN is composed of bilateral nuclei containing
approximately 10,000 neurons each. It receives photic input via a novel class of intrin-
sically light-sensitive retinal ganglion cells that express the photopigment melanopsin
and project the information to the SCN via the retinohypothalamic tract [80, 81]. The
SCN then relays the information to other regions in the brain and regulates all other
rhythmic cells, so called peripheral oscillators, in the body [82] through both, neu-
ronal and humoral signals, which are responsible for proper timing of hormone release,
feeding behavior and body-temperature fluctuations [10, 83] as well as other rhythmic
functions. Of interest, temporal feeding restriction under light-dark or dark-dark condi-
tions have been able to change the phase of circadian gene expression in peripheral
cell types by up to 12 hours, while leaving the phase of cyclic gene expression in
the SCN unaffected. Apparently, they thereby uncouple peripheral oscillators from the
central pacemaker [84]. Recent findings support a role of PARP1 (poly ADP-ribose
polymerase 1) in connecting feeding with the mammalian system [85].
Because of the large set of genetic tools available, the majority of research in mam-
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mals focuses on the mouse as a model organism to study the molecular basis of the
mammalian clock. One method of choice to monitor the output of the circadian clock
is by recording the wheel-running behavior of mice. Moreover, knock-in mice have
been engineered to express a luciferase-reporter under control of circadian promoters
such as the Per2-luc mice. Tissue explants of these have demonstrated that there is
a functional molecular clock on the level of almost every type of cell in the body [86].
Depending on the tissue, however, consistent luciferase rhythms can be found for vari-
able amounts of time. While the SCN contains a very robust circadian clock displaying
rhythmic luciferase expression for several weeks after explantation, the expression of
luciferase in peripheral oscillators dampens within a couple of days. Moreover, pe-
ripheral oscillators can be entrained to temperature rhythms, whereas the SCN itself
cannot [87].
Circadian studies on humans are mostly carried out by analyzing questionnaires,
comparing behavioral rhythms, and by identifying hormone and protein levels from
the blood. Nowadays the genetic basis of the human clock is directly explored to an
increasing extent by means of cell lines derived from human cells. One of the key cell
lines used to study the circadian clock in human cell culture is the U2OS cell line from
an osteosarcoma patient.
The core feedback loop in mammals will be discussed in detail in the next section.
1.3.2. Molecular mechanism
1.3.2.1. Main feedback loop
The core circadian clock in mammals consists of several interconnected transcription
translation feedback-loops which have been the subject of extensive research in the
past decade. The key players of the main regulatory loop are the transcriptional activa-
tors CLOCK (circadian locomotor output cycles kaput) [88, 89] or its paralogue in some
regions of the brain, NPAS2 (neuronal PAS domain protein 2)[90], as well as BMAL1
and -2 (Brain and muscle arnt like 1) [91, 92, 93] and their negative regulators PER1,
-2, and -3 (Period homologue 1, -2, -3) [94] and CRY 1 and -2 (Cryptochrome 1, -2)
[95, 96].
The two basic helix-loop-helix transcription factors CLOCK and BMAL1 form a het-
erodimer, which binds to consensus-E-box-sequences (CACGTG) in the promoter re-
gion of their target genes, among these the PER and CRY genes, thereby activating
their transcription [89, 91]. PER and CRY form a dimer in the cytosol where they un-
dergo further posttranslational modifications which regulate their activity and stability.
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Eventually, the PER-CRY-dimer binds to and becomes phosphorylated by CK1 (Casein
Kinase 1) and is translocated into the nucleus, where it represses its own transcription
through interaction with the CLOCK-BMAL1-heterodimer [97, 98]. As a consequence,
levels of newly synthesized PER and CRY decrease, while the existing PER-CRY re-
pressor complex is degraded, thus releasing repression and leading to new transcrip-
tional activation by BMAL1 and CLOCK (Figure 1.6).
Figure 1.6.: Central negative feedback loop of the circadian clock in mammals. The
bHLH-transcription factors BMAL1 and CLOCK bind to E-boxes in their
target genes and thereby activate their transcription. Among the target
genes are the CRY and PER proteins, which feedback on their own ex-
pression by negatively interacting with the BMAL1-CLOCK-heterodimer.
Post-translational modification and degradation are crucial steps for maintaining the
period of about 24 hours of the molecular clock. The basic mechanism of transcrip-
tional and translational feedback is maintained, adapted and supported by several other
regulatory pathways and interconnected feedback loops, which in many cases are not
clearly understood yet. Even the exact mode of activation by BMAL1 and CLOCK and
repression by PER and CRY in mammals is still a matter of ongoing research. Exper-
imental data and recent crystal structure analysis of the BMAL1-CLOCK heterodimer
suggests that CRY1 binds directly to CLOCK [99, 100] and that PER translocates the
inhibitor complex into the nucleus [101]. BMAL1 and CLOCK appear to remain bound
to DNA throughout the circadian cycle, where they are rhythmically inhibited, probably
via phosphorylation by various kinases and possible subsequent degradation of the
BMAL1-CLOCK, which could be replaced by the newer unphosphorylated heterodimer
[101, 102, 103]. More recent experiments have been able to show rhythmic binding of
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BMAL1 and CLOCK in mouse liver [5, 6].
PER and CRY also undergo several posttranslational modifications. Both, the PER
and the CRY proteins are progressively phosphorylated in the cytosol, which, among
other things, targets them for polyubiquitination and degradation by the 26S proteaso-
mal pathway. The turnover of PER and CRY is specifically regulated by two different
SCF (Skp1-Cullin-F-box) E3 ubiquitin ligase complexes, the β-TrCP1 (beta-transducin
repeat containing) [104] and FBXL3 (F-box and leucine-rich repeat protein 3) E3 ubiqui-
tin ligase complexes [105, 106], respectively. PER is phosphorylated by CK1ε (Casein
kinase 1ε) and CK1δ (Casein kinase 1δ) [107].
The three PER proteins and the two CRY proteins form a large nuclear complex, the
PER complex, which interacts with the BMAL1-CLOCK heterodimer to repress tran-
scription. Other constituents of this complex are CK1ε and CK1δ, as well as six RNA
binding proteins. The PER complex RNA-binding proteins PSF (PTB-associated splic-
ing factor), NONO (non-POU domain containing, octamer binding) and WDR5 (WD
repeat domain 5) act in transcriptional repression, that is probably achieved in part via
recruitment of the SIN3-HDAC (SIN3A-Histone Deacetylase) complex to clock gene
promoters, which promotes deacetylation at histones 3 and 4 [108]. The PER com-
plex components DDX5 (DEAD box helicase 5) and DHX9 (DEAH box polypeptide
9) on the other hand, appear to act on coupling between initiation and termination of
transcription. The latter one is likely achieved at the 3'-termination site by antago-
nizing the action of SETX (Senataxin), an RNA helicase that promotes transcriptional
termination. This impedes RNA Pol II release and thereby represses transcriptional
re-initiation [109].
1.3.2.2. Positive feedback via REVERB and ROR
When the CLOCK-BMAL1 dimer activates transcription of PER and CRY it also acti-
vates expression of the nuclear receptors NR1D1 and NR1D2, encoding for the pro-
teins REVERBα and REVERBβ, respectively. These functionally redundant proteins
strongly repress BMAL1-transcription and are therefore required for rhythmic BMAL1
expression [110, 111, 112, 113]. The more PER and CRY protein is produced, the
more they inhibit the CLOCK-BMAL1-dimer, resulting in less transcription of NR1D1
and NR1D2. BMAL1-transcription is thus de-repressed by lower REVERB protein lev-
els. REVERBα mediates transcriptional repression via NCoR1 (nuclear receptor core-
pressor 1), which activates the histone deacetylase HDAC3 [114, 115] (Figure 1.7).
Antagonistic to the function of the REVERB proteins is the function of the ROR (RAR-
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related orphan receptors) proteins [112, 116]. They contribute to BMAL1 amplitude but
are dispensable for BMAL1 rhythm [111]. REVERBs and RORs compete for binding
to specific ROREs (retinoic acid-related orphan receptor response elements) and re-
press or activate transcription, respectively [112]. Binding to ROREs was found in the
promoter of the BMAL1 gene as well as in the promoter of NPAS2 [117] and the first
intron of CLOCK [118]. This secondary loop is not essential, but it is thought to add
robustness to the molecular clock. PER2 has been found to rhythmically interact with
promoters of nuclear receptors, such as NR1D1 and thereby modulate their expression
[119]. Cryptochromes, on the other hand, appear to bind to glucocorticoid receptors
and repress glucocorticoid-receptor-dependent transcription [120].
1.3.2.3. Chromatin Remodeling
CLOCK has been shown to act as a histone acetyltransferase on histone H3 Lys-14
and Lys-9 [8] at the promoter of its target genes, thereby inducing a transcription-
permissive state. Furthermore, it can also specifically acetylate its binding partner
BMAL1 on Lys-537. This acetylation facilitates recruitment of CRY1 to CLOCK-BMAL1,
thereby promoting transcriptional repression [65]. The NAD+ dependent histone de-
acetylase SIRT1 (Sirtuin 1) interacts with CLOCK and rhythmically counteracts its
acetylation [121]. SIRT1 governs critical metabolic and physiological processes
through deacetylation of several regulatory proteins involved in the control of metabo-
lism, including members of the FOXO (Forkhead Box, subclass O) protein family [122],
PGC-1α (Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Coactivator
1A), and the nuclear receptor LXR (Liver X Nuclear Receptor) [123]. CLOCK and
SIRT1 contribute to circadian chromatin remodeling at the promoter of NAMPT (Nicoti-
namide Phosphoribosyltransferase) promoter [124] which is a key enzyme in the NAD+
salvage pathway. Thus, SIRT1 contributes to the circadian synthesis of its own coen-
zyme, NAD+, which tightly couples cellular metabolism and circadian physiology (Fig-
ure 1.7). Interestingly, histone acetylation and BMAL1 acetylation occur nearly in an-
tiphase, pointing to a dual role, first in activation of target genes and later in their
repression. Other histone-modifying enzymes, such as JARID1a (Jumonji, AT Rich In-
teractive Domain 1a), also seem to influence circadian transcription. JARID1a forms a
complex with CLOCK-BMAL1, which is recruited to the Per2 promoter. It increases his-
tone acetylation by inhibiting histone deacetylase 1 function and enhances transcription
by CLOCK-BMAL1 in a demethylase-independent manner [125].
A recent profile of the epigenetic landscape in mouse liver [6] showed that on a
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genome-wide scale there are rhythms in RNA polymerase II recruitment and initiation,
as well as in histone H3 trimethylation (H3K4me3) and acetylation (H3K9ac, H3K27ac),
which occur at thousands of expressed genes whether or not RNA cycling was de-
tectable. It was suggested that circadian transcriptional regulators appear to be in-
volved in the initial stages of RNA polymerase II recruitment and initiation and that the
histone modifications associated with these events set the stage for gene expression
on a global scale, but that additional control steps must then determine the ultimate
transcriptional outputs from these sites.
Figure 1.7.: Interplay between regulators of circadian clock and metabolism. Some
clock controlled genes are regulators of metabolic pathways, and oth-
ers can influence metabolite levels. Nutrient sensors AMPK and SIRT1
are regulated in a circadian manner, and they can modulate circadian
rhythms and metabolism by post-translational modifications of key regu-
lators. Figure and Legend from Sahar and Sassone-Corsi [126].
1.3.2.4. Link to metabolism via AMPK and the PPAR proteins
Both, CRY1 and Casein kinase 1ε, have recently been found to be phosphorylated by
AMPK (AMP-activated protein kinase), which leads to increased degradation of CRY1
[127] and PER2. This mechanism allows nutrient signals to feed back on the core cir-
cadian clock because AMPK is activated when the ratio of AMP/ATP is high, signaling
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that the overall cellular energy status is low (Figure 1.7). Moreover, the activity of AMPK
was found to be rhythmic in mouse liver, hypothalamus, and fibroblasts [127, 128].
Another important link between circadian clocks and metabolism has been estab-
lished in recent years based on the nuclear receptors from the family of the peroxi-
some proliferator-activated receptors (PPARs). Three subtypes of PPARs are known:
PPARα, PPARδ, and PPARγ. The expression of the different PPARs exhibit charac-
teristic but distinct tissue-specific rhythms in mouse. PPARA transcripts cycle in both,
white and brown adipose tissue and in liver but not in muscle. It is known for its role in
promoting hepatic fatty acid oxidation and ketogenesis in response to fasting. PPARG
selectively cycles in white adipose tissue and liver and is most abundant in adipose
tissue, where it activates transcriptional programs for lipid storage and lipogenesis,
whereas PPARD transcripts oscillate only in brown adipose tissue and liver [129].
Not only are the PPARs expressed in a rhythmic manner, they also provide a feed-
back on expression of important core clock genes themselves. PPARγ directly induces
expression of NR1D1 in adipose tissue of mice by binding to its promoter [130]. On
the other hand PER2 was shown to directly regulate PPARγ in white-adipose tissue
by blocking PPARγ recruitment to target promoters and thereby inhibiting transcrip-
tional activation. This mechanism is conceptually different from the repression that
PER2-CRY exerts on CLOCK-BMAL1 and does not require CRY [131]. The coactiva-
tor of PPARα, PGC-1α, provide further feedback to the circadian network. PGC1A was
found to be rhythmically expressed in liver, brown adipose tissue, and skeletal muscle
of mice [129, 132]. It stimulates the expression of clock genes, notably BMAL1 and
NR1D1, through coactivation of the ROR family of orphan nuclear receptors [132].
1.3.2.5. Fine-tuning via the DEC proteins
The clock-controlled proteins DEC1 (Differentiated embryo chondrocyte 1) and DEC2
play a role in the fine-tuning of the circadian clock. Both proteins are bHLH transcrip-
tion factors like BMAL1 and CLOCK and suppress BMAL1-CLOCK-enhanced promoter
activity through competitive binding to canonical E-boxes (CACGTG) [133], thus influ-
encing the phase of expression of genes that contain this motif in their promoter re-
gion, such as DEC1 and -2 themselves, as well as PER1, DBP, and NR1D1. But
unlike BMAL1 and CLOCK they do not bind to E'-boxes (CACGTT) and therefore do
not affect the phase of PER2 and CRY1 [134].
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1.3.2.6. D-box regulation via the bZIP proteins
There are four proteins of the bZIP (basic leucine zipper) family that are regulated in
a circadian fashion and affect circadian output target genes by interacting with D-box
elements in the promoter region. The PAR (proline and acidic amino acid-rich) bZIP
proteins DBP (albumin D-site-binding protein), HLF (Hepatic leukemia factor), and TEF
(Thyrotroph embryonic factor) are highly rhythmic transcriptional activators in several
tissues, including liver, SCN and kidney [1, 135, 136]. The rhythmic bZIP transcription
factor E4BP4 (E4 promoter-binding protein) is expressed in antiphase to DBP, HLF and
TEF and functions as a negative regulator of D-boxes. Whereas the positive activators
are able to dimerize, E4BP4 is not, but it can compete for the same binding sites
with them [137]. The PAR bZIP transcription factors modulate the expression of many
proteins involved in detoxification and drug metabolism [138]. Cellular DBP and E4BP4
proteins are critical for determining the circadian period length and have reciprocal
effects on it [139].
1.3.3. Physiological rhythms and pathophysiology
The circadian clock influences important physiological processes, such as the proper
timing of hormone release, feeding behavior, cardiovascular- and renal activity, the
hepatic metabolism, and body-temperature fluctuations [10, 83, 140]. The SCN is the
master pacemaker that senses light and relays timing information to peripheral clocks
in the body via different pathways. Diurnal body-temperature fluctuations have been
found to entrain peripheral oscillators, but not the SCN [87]. Recent analysis of cy-
cling transcripts in mice with and without a functional liver clock showed, that rhythmic
transcription of most genes in this organ depended on a functional hepatocyte clock,
whereas a small set of other genes were circadianly expressed even in the absence of
a liver clock, among these Per2. Rhythms in these genes were probably generated by
systemic signals [141] and could provide another mechanism by which peripheral os-
cillators are entrained by the SCN. Moreover, several pathways have developed to also
allow a feedback of information about the metabolic state of a cell to its local circadian
system. An example for this is the finding that peripheral oscillators can be uncoupled
from the central pacemaker by restricted feeding [84]. In order to establish communi-
cation between circadian clocks and metabolism, sensors affecting both systems exist.
Among these are redox sensors, AMP/ATP ratio sensors, glucose sensors, and fatty
acid sensors [83].
The entire circadian system has evolved to optimize an organism’s performance over
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the course of the day and to maintain homeostasis by keeping various physiological
processes in balance. When this equilibrium is lost, for example by rotating shift work,
it can increase the risk of developing severe diseases. Shift-work and sleep depriva-
tion have been found to dampen rhythms in growth hormone and melatonin secretion,
reduce insulin sensitivity, and elevate circulating cortisol levels. These changes favor
weight gain, obesity, and development of metabolic syndrome [142]. Along the same
line, loss of adequate blood pressure decline during the sleep period has been found
to be a significant risk factor for cardiovascular organ damage [143].
Hamsters with a point mutation in casein kinase-1ε, the so called tau mutation, have
a 22-hour rather than a 24-hour circadian cycle. When kept under a 24-hour cycle
(light/dark, 12 h/12 h) these hamsters developed cardiomyopathy and severe renal
disease which was reversed when they were kept under a 22-hour cycle, the length
of their intrinsic rhythm, or when the SCN was ablated. This impressively shows, that
not the disruption of the circadian clock, but the desynchrony between the internal and
external clock were responsible for the development of cardiovascular disease [144].
Similar effects were observed in mice [145].
Probably the most obvious output of the circadian clock in humans is the rhythmic
pattern of sleep and wakefulness, the timing of which is regulated by two processes: a
sleep homeostatic process that underlies the rise of need for sleep during wakefulness
and a circadian process that determines the threshold for switching between sleep
and wake. Several sleep disorders have been clearly linked to circadian alterations
in the timing of sleep such as the advanced sleep phase syndrome and the delayed
sleep phase syndrome. FASPS (Familial advanced sleep-phase syndrome) was the
first human sleep disorder, where a direct link to a known core clock gene was found.
FASPS is inherited in an autosomal dominant fashion and is characterized by persistent
3-4 hours advanced sleep onset- and waking times. This causes affected individuals
to not be able to function on the conventional time scale in society and work-life, often
leading to depression. FASPS results from the missense mutation S662G in PER2,
which coincides with a phosphorylation site within its CK1 binding domain. The missing
phosphorylation site appears to cause a faster turnover of nuclear PER2, either by
enhanced degradation or by reduced nuclear retention of PER2 [146, 147].
1.3.4. Relation between clocks, cell cycle, and cancer
In the last decade many connections of various core clock proteins to cell cycle con-
trol and the development of cancer have been found. The finding that disruption of
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circadian rhythms led to increased mammary tumor development was first reported in
the 1960s [148]. Since then, several epidemiological studies have pointed to an ef-
fect of a de-regulated circadian clock on the development of cancer. Among these are
studies that show that female shift-workers have a higher predisposition for developing
cancer, which increases with the number of years and hours per week that individuals
spent working at night [149, 150]. Moreover, disruption of circadian rhythms appears to
accelerate tumor progression, which was studied in SCN-ablated mice [151]. There is
direct evidence that demonstrates an association between loss of human PER1, PER2,
and PER3 function and breast- and endometrial cancer. One study showed that 95%
of breast tumors display no or deregulated level of PER1, PER2, or PER3 proteins
compared to adjacent normal tissues [152].
On the molecular level the BMAL1-CLOCK heterodimer appears to control the ex-
pression of many genes that are involved in the cell cycle. Several reports show
rhythmic expression of major proto-oncogenes like c-MYC (v-myc myelocytomatosis
viral oncogene homolog (avian)) and MDM2 (Mouse Double-Minute), as well as tumor-
suppressor genes like P53, and GADD45α (Growth Arrest And DNA-Damage-
Inducible, alpha) [1, 153, 154]. The c-Myc promoter appears to be suppressed by
BMAL1-CLOCK, whereas CRY1 relieves repression [153]. WEE1 kinase, which reg-
ulates the timing of G2/M transition [155] and METAP2 (Methionyl Aminopeptidase)
which is important in cell cycle initiation in eukaryotes [156, 157] are also directly con-
trolled by BMAL1 and CLOCK. PER1 was found to interact with both, ATM (Ataxia-
Telangiectasia Mutated) kinase and CHK2 (Checkpoint Kinase 2), which are involved
in the cellular response to ionizing radiation and DNA double-strand-break-inducing
events [158]. REVERBα, in turn, has been found to regulate expression of the cell
cycle inhibitor p21WAF1/CIP1 [159]. The protein NONO that is bound in the PER inhibitor
complex acts together with PER to rhythmically activate the promoter of the cell cycle
checkpoint gene p16-INK4A, which regulates G1/S transition [160].
Although CRY1 and CRY2 have structural similarity to photolyases, proteins involved
in the repair of UV-damaged DNA, biochemical evidence of participation in DNA-repair
is still missing [161]. A study on Cry1-/- and Cry2-/- mice even reports no effect of
either cry knockout on spontaneous and ionizing radiation-induced cancers [162].
All these observations lead to the assumption, that there is a common pathway
shared by regulators of the circadian clock and cell proliferation. This pathway need not
to be shared at all the times, but may come into play in stress-situations only, like after
irradiation-induced DNA-damage, and therefore be opportunistic and episodic rather
than operating at all times [161].
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1.4. Binding motif of BMAL1 and CLOCK
The core transcriptional activator in mammals is a heterodimer of BMAL1 and CLOCK,
which both are basic helix-loop-helix (bHLH) PAS domain proteins. There are more
than 125 different bHLH proteins [163], which are classified by sequence in A - F.
BHLH proteins can form homo- and heterodimers mediated by their HLH domain [164]
and, in case of class C, as for BMAL1 and CLOCK, also by their PAS-domain [100]. At
the amino-terminal end of the bHLH region is the basic domain, which binds the tran-
scription factor to DNA at a consensus hexanucleotide sequence known as the E-box.
Different families of bHLH proteins recognize different E-box consensus sequences
and dimerization with different partners can shift affinities [163]. BMAL1 and CLOCK
were found to bind to E-box motifs with the consensus sequence CACGTG (allowing
up to one mismatch) or double E-box motifs containing two E-box sequences (with up
to 3 mismatches total) in tandem with a short interval of six nucleotides between them
[5, 6, 165]. Very recently, it was suggested that BMAL1 and CLOCK bind to a 7-bp
sequence rather than a 6-bp motif, and that two noncanonical E-boxes were bound
with high affinities, consisting of the sequences AACGTGA and CATGTGA [166]. The
former motif has been observed as a 6-bp E’-box CACGTT to account for most of the
transcriptional drive in the mPer2 promoter [167].
1.5. Project Aim: Analysis of binding of the circadian
transcription regulators in human cells
Many cellular pathways are influenced by the circadian clock and an important aim of
the field of chronobiology is to find out which genes or proteins the circadian clock di-
rectly acts on. Mouse experiments suggest that around 10% of all actively transcribed
genes in mammals could be clock-controlled and that they are highly tissue specific
[1]. The molecular basis of tissue specificity of circadian gene expression, however,
is not yet understood. Many published works have therefore focused on identifying
oscillating mRNA expression in various organs through microarray experiments using
mouse tissue extracts [1, 3, 168, 169, 170]. In recent years, our group, as well as
some other groups, have used a new approach for finding direct targets of the cir-
cadian clock on a genome wide scale in various organisms [5, 6, 171, 172]. This
approach is based on the combination of Chromatin-Immunoprecipitation (ChIP) of the
core transcriptional activator(s) of the circadian clock, followed by deep sequencing, so
24 1 Introduction
called ChIP-sequencing or ChIP-seq. Using this method rhythmic binding of BMAL1
has been observed in 2047 target genes in mouse liver [5]. Most studies so far have
been performed in mice, because tissue extracts of wild type and knockout animals un-
der controlled conditions are readily available. Lately, advances in studying the human
clockwork have been made due to the fact that some immortal cell lines contain a func-
tional circadian clock which can be reset by stimuli like dexamethasone or entrained
to temperature rhythms. One cell line that has been used in various circadian studies
is the U2OS cell line derived from human osteosarcoma cells [2, 3, 4] with which all
experiments in this work have been performed.
A stringent genome-wide transcriptome analysis in U2OS did not find any rhythmic
transcripts besides seven core clock genes [3]. In this work we want to analyze whether
the core circadian transcription factors bind to and regulate fewer genes in U2OS than
in mouse liver. Therefore we expanded the ChIP-seq approach to find genes that are
bound by three key players of the mammalian circadian clock, BMAL1, CLOCK, and
CRY1, and combined ChIP-seq binding site analysis and motif search in U2OS cells
with microarray data of a two-day RNA time course in the same cell type. With this
data at hand, further analysis was carried out to gather insights into the functionality
of the obtained binding sites by producing U2OS cells that stably expressed promoter-
luciferase constructs of promoters that contained or lacked binding sites for BMAL1 and
CLOCK. The combination of these experiments increases the insight into the circadian
clock of U2OS cells and poses a hypothesis for tissue specificity.
2. Material and Methods
2.1. Material
2.1.1. Organisms
2.1.1.1. Cell lines
Most experiments were performed with cell lines derived from the human osteosar-
coma cell line U2OS. These cells express a functional circadian clock and are therefore
used as a model system for clocks in humans. J. Ponten and E. Saksela derived this
line (originally called "2T") in 1964 from a moderately differentiated sarcoma of the tibia
of a 15-year-old girl. The cultures were started from a non-necrotic intraosseous part
of the tumor obtained at the time of amputation of the left leg. This cell line was first
found to be hypodiploid [173]. The culture collection ATCC (American Type Culture
Collection) received the U2OS cell line in 1982 from the Human Tumor Cell Bank at
passage number 28. ATCC found that U2OS cells are not hypodiploid but contain on
average 76 chromosomes per cell and that normal chromosome representation was
low. Most of the chromosomes were monosomic and 22 stable marker chromosomes
had formed by rearrangement of several of the missing chromosomes, particularly of
chromosomes 1, 7, 9, and 11. The U2OS cells used in this work were received at pas-
sage number 28. It is uncertain whether the described rearrangements can be found
in these U2OS, because changes appear to be quite frequent.
In a study comparing 6 different osteosarcoma cell lines, U2OS had the lowest level
of chromosomal numerical variations and showed the most normal pheno- and geno-
type concerning the genes P53, RB1, and MYC [174]. Although the MYC gene was
5 times amplified, induction upon serum-stimulation appeared to function normally.
U2OS were the only osteosarcoma cells with a non-mutated P53 [175]. Therefore,
even though it is a tumor cell line, it seems to be a comparably good system for study-
ing circadian rhythms in humans and it allows researchers to use genetic tools in a
human cell line. So far several studies have been carried out, including knock-down
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studies [2, 4, 176], experiments with rhythmic BMAL1-promoter-luciferase constructs
[4], as well as studying rhythmic expression of genes on a genome-wide scale [3].
While tissues in the body are constantly synchronized by the SCN, this synchrony is
lost over time in all explanted tissues, a phenomenon called dampening. When work-
ing with cell lines it is therefore necessary to be able to reset the clock. This is often
performed by adding high amounts of serum for a short amount of time [7] or by using
the glucocorticoid dexamethasone [3, 177]. Recent studies have shown that some cell
lines, such as NiH-3T3 cells [146] and U2OS cells (unpublished data) can be entrained
to temperature rhythms as well, providing a convenient method to obtain a consistent
rhythm without upsetting the system by addition of metabolites.
In this work single cell clones of U2OS cells stably expressing promoter-luciferase
constructs were generated using lentiviral transduction or transient transfection and
selection. For lentiviral transduction a modified U2OS cell line, U2OSmcat (generated
by Dr. Claudia Seelenmeyer), was used as target cell line. This cell line was selected
with the antibiotic zeocin to stably express the murine MCAT (Murine Cation Trans-
porter) receptor on its surface [178], thus allowing virus entry into a human cell line
via a mouse-specific protein from the pV Pack Eco System. The stable cell lines that
have been used for this work are listed in Table 2.1. U2OS BMAL1-luc was described
previously [4].
Table 2.1.: U2OS single cell clones that stably express promoter-luciferase con-
structs. From each cell line several single cell clones were grown and
used. The single cell clones used to obtain the data shown in the results-
section are named first. In parenthesis are other clones that produced
good rhythms. GAPDH-luc cell lines were not rhythmic.
Cell line plasmid luciferase promoter Single cell clone
U2OSmcat pSIN_MCS luc2P ATG3 B11 (E6, E8)
U2OSmcat pSIN_MCS luc2P EIF5A2 E8 (E10)
U2OSmcat pSIN_MCS luc2P GAPDH G3 (C7)
U2OSmcat pSIN_MCS luc2P SCN5A E8 (G7)
U2OS pGL4.20 luc2 CRY1 E2 (E3, G7)
U2OS pGL4.20 luc2 NR1D1 D5 (C7, C9)
U2OS pGL4.20 luc2 PER2 E4 (B8, B7)
U2OSmcat pSIN_MCS luc2 PER2 B9 (D7)
HEK (Human Embryonic Kidney) 293T cells are the highly transfectable derivative of
the 293 cell line into which the temperature sensitive gene for SV40 (Simian Virus 40)
T-antigen was inserted. These cells have been developed specifically for the purpose
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of high transfectability and their capacity of producing high titer of infectious retrovirus.
In this work they were used to produce the virus containing the promoter-luciferase
constructs of interest using the pV Pack Eco System.
2.1.1.2. Escherichia Coli
Escherichia coli (E.coli) is a Gram-negative, rod-shaped bacterium from the family of
Enterobacteriaceae of the Gammaproteobacteria. It is commonly found in the lower
intestine of endothermic organisms and forms part of the gut flora. It is about 2 µm
long and 0.5 µm in diameter. E.coli was one of the first organisms to have its genome
sequenced [179]. Due to its rapid division rate of 20-30 minutes in culture and its
well known and simple genetics it has become a widely used model organism. Apart
from this function, it is used ubiquitously as a host and propagator for DNA plasmids
as well as for protein overexpression. In this work the competent E.coli strains DH5α
(Invitrogen) and XL-1 blue (Agilent Technologies) were transformed for propagation of
plasmids.
2.1.1.3. Murine leukemia virus
Murine leukemia viruses (MLV) belong to the γ-retroviral genus of the Retroviridae fam-
ily. Retroviruses are RNA viruses that replicate through an integrated DNA intermedi-
ate. Retroviral particles encapsidate two copies of the full-length viral RNA, each copy
containing the complete genetic information needed for virus replication. Retroviruses
possess a lipid envelope and use interactions between the virally encoded envelope
protein that is embedded in its membrane and a cellular receptor to enter a host cell.
After entering a host cell the virally encoded enzyme Reverse Transcriptase produces
a DNA-copy of the viral RNA using reverse transcription. Viral DNA is permanently
integrated into the host genome by the virally encoded integrase and is referred to as
provirus. The transcription and translation machinery from the host cell carries out
expression of the viral genes. Newly synthesized viral proteins and full-length RNAs
are assembled together to form new viruses that bud out of the host cells (Figure 2.1)
[180].
MLV encodes the retroviral genes gag (group-specific antigen), pro (protease), pol
(polymerase), and env (envelope). The gag gene codes for the Gag polyproteins that
make up the viral capsid. After assembly of the virus particle, this polyprotein is prote-
olytically cleaved into several proteins. The pol gene encodes Reverse Transcriptase
as well as Integrase. The env gene codes for the Envelope polyprotein, which is also
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Figure 2.1.: Life-cycle of a retrovirus, as described in the text. Figure from Hu and
Pathak [180].
cleaved into two parts. Viral DNA contains large redundant sequences at both ends of
the genome, designated long terminal repeats (LTR). These can be further divided into
U3 (unique 3'), R (repeat), and U5 (unique 5') regions. Viral promoters and enhancers
are located in the U3 region. The R region is essential for reverse transcription and
replication of all retroviruses. In addition MLV also contains a polyadenylation signal.
The U5 region contains sequences that facilitate the initiation of reverse transcription
[180]. The viral packing signal (Ψ) is required for the viral RNA to be packaged into
virion particles. Sequences extending into the gag open reading frame can enhance
the efficiency of packaging and are called Ψ+ [181].
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2.1.2. Plasmids
2.1.2.1. pGL4.20
Figure 2.2.: Vectorcard of pGL4.20 as provided by the manufacturer (Promega). The
vector encodes for luc2 and contains a puromycin resistance for selec-
tion of stable cell lines. Promoter constructs were cloned into the vector
according to Table 2.2.
The plasmid pGL4.20 (Figure 2.2) was obtained from Promega. It contains a syn-
thetic firefly (Photinus pyralis) luciferase2 (luc2), which has been codon-optimized for
more efficient expression in mammalian cells. Moreover pGL4.20 contains a puromycin
resistance for selection of stable cell lines. The vector neither contains promoter nor
enhancer elements. The promoter regions of human CRY1, NR1D1 and PER2 were
amplified from U2OS gDNA and cloned into the multiple cloning site (MCS) of this vec-
tor. Information on the promoter and the restriction enzymes that were used are listed
in Table 2.2.
Table 2.2.: Promoter-luciferase constructs were generated with the promoters of the
known clock-controlled genes CRY1, NR1D1, and PER2. Information on
promoter-regions and flanking restriction sites are shown.
Gene Region (bp from TSS) Length (bp) Restr.Enzymes
CRY1 -1107 to +799 1906 NheI, HindIII
NR1D1 -858 to +625 1483 NheI, BglII
PER2 -848 to +204 1053 SacI, HindIII
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2.1.2.2. pSGG_prom
BamH1
Figure 2.3.: The plasmid pSGG_prom as provided by the manufacturer (SwitchGear
Genomics). Constructs were cut using MluI and BamHI. The antibiotic
marker was ampicillin.
The promoter-luciferase constructs for ATG3-luc2P, EIF5A2-luc2P, GAPDH-luc2P,
and SCN5A-luc2P were purchased from SwitchGear Genomics and delivered in the
plasmid pSGG_prom with the information provided in Figure 2.3 and Table 2.3. The
vector is derived from the pGL4 family of vectors (Promega) and contains a multiple
cloning site, luciferase2P (luc2P), and an ampicillin resistance for propagation in E.coli
cells. Luc2P is a modified version of luc2 harboring a destabilizing c-terminal PEST
sequence, reducing its half-life from 3 h to 1 h. Destabilized reporter proteins are
expected to be more responsive and better suited to monitor rapid processes than
those with slower degradation rates. In circadian biology their advantage is that they
provide a better signal-to-noise ratio. The entire promoter-luciferase2P region was
cloned into the vector pSIN_MCS after digestion with the enzymes MluI and BamHI.
Table 2.3.: Information on promoter-luc2P constructs as provided by Switch Gear Ge-
nomics.
productID gene chr start end strand length (bp)
108396 ATG3 chr3 113763005 113763997 - 992
106995 EIF5A2 chr3 172109014 172109967 - 953
121624 GAPDH chr12 6513163 6514226 + 1063
109730 SCN5A chr3 38665940 38666935 - 995
2.1 Material 31
2.1.2.3. pSIN_MCS
Figure 2.4.: Vectorcard of pSIN_MCS. The vector contained the retroviral elements
5'-LTR and 3'SIN-LTR and the viral packaging signal Ψ+ (orange). For
cloning, two restriction sites in the MCS (pink), MluI and BamHI (light
blue), were used. The plasmid contains an ampicillin-resistance (green).
This vector is an adapted version of the pSIN.Bi-F3-lg-F plasmid which was devel-
oped by Dr. Ina Weidenfeld [182] and modified by Christian Nahstoll. The pSIN.Bi-
F3-lg-F plasmid is a derivative of the self-inactivating (SIN) Moloney Murine Leukemia
Virus-based retroviral vector S2f-lMCg [183] and can be used for retrovirus production.
SIN vectors distinguish themselves from conventional γ-retroviral vectors by deletions
within the U3 sequence of the 3'-LTR, which covers the LTR promoter and enhancer
region. Upon reverse transcription and genomic integration, the γ-retroviral vector will
carry the SIN-LTR at both, the 3'- and the 5'-end [184]. Thus, transcription of a gene of
interest inserted between both LTRs is not regulated by the strong viral promoters but
by a promoter which must be specifically inserted along with the target gene between
the LTR regions. In the pSIN_MCS a 3.5 kb large fragment of the pSIN.Bi-F3-lg-F,
containing a Tet promoter, luciferase, and GFP was substituted with a multiple cloning
site which was used for cloning promoter-luciferase constructs from the pSGG_prom
into the pSIN_MCS vector using the restriction enzymes BamHI and MluI.
The retroviral elements in this plasmid include the extended version of the viral pack-
aging signal Ψ+, the 5'-LTR, and the 3'SIN-LTR [182] (Figure 2.4).
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2.1.3. Antibodies
2.1.3.1. Peptide antibodies
For this work four peptide-based antibodies against the proteins BMAL1, CLOCK,
CRY1, and CRY2 (Table 2.4) were generated by Pineda Antikörper-Service. Three-
month-old rabbits were repeatedly immunized with specific peptides and blood was
collected every 30 days. The sera were tested for specificity using western blot, be-
ginning 60 days after the first immunization. The peptides contained a cystein at the
n-terminus, which allowed purification of the antisera through peptide-bound columns
via disulfide-bridges. Antibodies were tested for specificity against the peptide on west-
ern blots with U2OS total protein extracts (Figure 2.5).
Table 2.4.: Four peptide-antibodies were generated against the core clock proteins
BMAL1, CLOCK, CRY1, and CRY2. All, except for CRY2 were used for
ChIP-sequencing. For each antibody two rabbits were immunized (R1,
R2). The antibody with the highest affinity was purified from serum at the
indicated number of days after first immunization (d150, d230).
Target Designation Animal and day Peptide
BMAL1 BMAL1 c-term R2 d230 CLEADAGLGGPVDFSDLPWPL
CLOCK CLNT R2 d150 CIFDGLVEEDDKDKAKRVS
CRY1 CRY1 c-term R1 d150 CQEEDTQSIGPKVQRQSTN
CRY2 CRY2 c-prox R2 d150 CLEAAEEPPGEELSKRARVAE
72
55
Serum Serum
Peptide
Purified
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95
130
Pre-
immune
Serum Serum
Peptide
Purified
CLOCK
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Figure 2.5.: Western blots showing specificity of the generated peptide-antibodies.
Antibody-specificity was analyzed with U2OS total extracts, comparing
serum (1:1000), peptide-blocked-serum (serum: 1:1000, peptide: 10
µg/ml), and affinity-purified antibody (BMAL1 - 1:750, all others: 1:300).
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2.1.3.2. Commercial antibodies
The secondary goat-anti-rabbit antibody, conjugated to horseradish-peroxidases is
commercially available from BIORAD.
2.2. Methods
2.2.1. Collaborations
Bioinformatical analysis of the data from ChIP-seq and microarray experiments were
carried out in collaboration with Prof. Felix Naef and Laura Symul at the École Poly-
technique Fédérale de Lausanne (EPFL), Switzerland. Descriptions of the analyses
were adapted from Laura Symul.
Microarray design and analysis was done in collaboration with Dr. Tamás Fischer,
Biochemistry Center of the Heidelberg University, Germany.
FACS sorting was carried out by Dr. Monika Langlotz, Center for Molecular Biology
of the Heidelberg University (ZMBH), Germany.
HEK 293T, U2OS, and U2OS BMAL1-luc were a kind gift of Prof. Achim Kramer,
Charité Berlin, Germany.
2.2.2. Cultivation of mammalian cells
2.2.2.1. Growing and passaging of cells
For all experiments which did not require temperature entrainment, U2OS cells were
grown at 37°C with 5% CO2. Cells were cultured in DMEM (Dulbecco’s modified Eagles
medium) with 4.5 g/L glucose, supplemented with 10% (v/v) FCS (Fetal Calf Serum)
and Penicillin/Streptomycin (Final conc.1x). HEK cells and U2OS cells, as well as
its derivatives, grow adherent in monolayers on the surface of non-coated cell culture
dishes.
Protocol: Cells were washed once with PBS and then incubated with 0.9 ml Trypsin-
EDTA for 8-10 min at 37°C. The serine protease trypsin interferes in cadherin-mediated
cell-cell adhesion. EDTA (Ethylenediaminetetraacetic acid) sequesters Ca2+ ions,
making the cadherins susceptible to trypsin. Cells were taken up in 10 ml growth
medium and resuspended by pipetting. For U2OS cells 1 ml was kept and the rest was
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discarded, whereas only 0.5 ml were kept from the fast-growing HEK cells. This way
cells were passaged twice a week. All chemicals were obtained from PAA.
2.2.2.2. Freezing and thawing cells
In order to use cells with comparable passage numbers and to prevent mycoplasma
contamination, a new stock of cells was thawed every 6-8 weeks. Moreover, each
thawed aliquot was first treated for a week with MRA (Mycoplasma Removal Agent
from MP) and handled in a separate incubator before cells were released for experi-
ments.
Protocol Freezing: A 2x cryomedium containing growth medium (40%), FCS (40%),
and DMSO (Dimethyl sulfoxide, 20%) was freshly prepared and sterile filtered. DMSO
is a cryoprotectant, which reduces ice formation and thereby prevents cell death during
the freezing process [185]. One 100 mm dish was used for freezing two 1 ml-aliquots of
cells. The cells were washed with PBS and trypsinized as described above. Cells were
sedimented by centrifugation at 200 g for 5 minutes. Pellets were dislodged by flicking
and taken up in 1 ml growth medium. Directly before aliquoting 1 ml cryomedium was
added. Cells were frozen in a special container with isopropanol at -80°C. The iso-
propanol enables cells to freeze at the rate of about 1 K per hour, thereby preventing
cell damage [185]. After 3 days cells were put in liquid nitrogen for long-term storage.
Protocol Thawing: Frozen cells were thawed quickly in a water bath and were then
directly diluted in 20 ml growth medium and centrifuged at 200 g for 5 minutes. The
pellet was resuspend in 10 ml growth medium and 1 ml was put into a 35 mm dish
and filled up to 1.5 ml with growth medium and MRA (at a final dilution of 1:100). The
rest was kept at 37°C without MRA as a backup or for freezing new cell stocks, which
were then marked as "px+1", referring to them being passaged one more time than the
original stock. During the incubation with MRA cells were split once to provide fresh
medium and MRA. After treatment cells were passaged into 100 mm dishes. When
these dishes were confluent, the cells were ready to be used for experiments.
2.2.3. Generation of stable cell lines
U2OS cell lines were generated which stably expressed the luciferase gene under con-
trol of the human promoters of the three core clock genes CRY1, NR1D1 and PER2,
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as well as promoters of ATG3, EIF5A2, and SCN5A, which contained a ChIP-seq bind-
ing site. For control, a cell line expressing luciferase under the GAPDH-promoter was
generated. Core clock promoter-luc2 constructs were generated by transfection and
selection, while the other promoter-luc2P cell lines were produced using lentiviral trans-
duction. U2OS PER2-luc2 was generated in both ways.
2.2.3.1. Transfection
Transient transfection was performed using Lipofectamine2000 (Invitrogen) according
to the manufacturer’s protocol for the 24-well format. U2OS cells are very sensitive
to transient transfection and transfection efficiency usually ranges between 10-50 %.
HEK cells show consistently high transfection efficiencies.
Protocol: One day before transfection 150,000 cells were plated in 500 µl DMEM
supplemented with 10% FCS. For transfection 0.8 µg plasmid and 3 µl Lipofectamine
were diluted in 50 µl Optimem each. After 5 min incubation the Optimem-Lipofectamine
mix was added to the Optimem-plasmid mix and incubated for 20 minutes. 100 µl of
this mixture were added dropwise to the cells, which were then incubated for 18-22
hours at 37°C. After incubation the medium was exchanged to DMEM containing FCS
and Penicillin/Streptomycin.
For selection, 24 hours after transfection cells were trypsinized and split onto two 35
mm dishes, which corresponded to a dilution of 1:12, needed for selection using antibi-
otics. When cells were diluted less than this, more negative cells survived selection.
24 hours later the antibiotic for selection was added to the medium. It took 2-3 weeks
until resistant cells filled one 35 mm dish under selection. During this time medium was
changed twice a week and cells were trypsinized regularly to support growth. Selec-
tion medium was applied 24 hours after trypsinization. The smallest effective dosage
of puromycin was 1.3 µg/ml, which was used for all experiments, but five times higher
doses were tolerated as well. When cells reached confluence in a 100 mm dish, single
cells were sorted into 3 - 4 white 96-well clear-bottom plates using FACS according to
the standard protocol. Two aliquots of unsorted cells were frozen before sorting.
2.2.3.2. Viral transduction
MLV-based vectors are very commonly used for gene therapy studies and for producing
stable cell lines, because they efficiently stably integrate the gene of interest into the
genome of a target cell line. In order to provide more safety all the cis and trans
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elements required for producing and packaging infectious viruses with the desired gene
of interest are separated onto three plasmids, with minimal or no sequence overlap
between them, thus reducing the possibility of homologous recombination between the
vectors. A host cell line, 293T HEK, is used to produce the virus for infection. Once
the viral RNA is encapsidated, virus particles bud off and are released into the cell
supernatant. The supernatant is then used for infecting target cells. The produced
virus itself, although capable of infecting cells, is replication-deficient. The Eco-plasmid
containing the envelope-gene allows to produce ecotropic MLVs which are capable of
infecting cells expressing the murine MCAT receptor.
Viral transduction was performed using the pVPack Eco-System (Agilent) according
to the manufacturer’s protocol with the exception of upscaling the virus-production to
100 mm dishes.
Protocol: Four million 293T HEK cells were plated on a collagen-coated 100 mm
dish. For collagen-coating 1 ml of a collagen-solution was dispersed on a 100 mm
dish and allowed to dry under the hood. 9 µg each of the plasmids pSIN_MCS which
contains the gene of interest, the pV Pack-GP, that codes for gag and pol, and pVPack-
Eco which encodes the envelope protein eco, were combined in one tube. Then 1 ml
of 100% (v/v) ethanol and 0.1 volume 3 M sodium acetate were added to the plasmids.
After mixing by inverting the tube, the DNA was precipitated at -80°C for 30 minutes
and collected by centrifugation at 12,000 g for 10 minutes at 4°C. 1 ml 70% ethanol was
added to the pellet, vortexed briefly, and centrifuged again at 12,000 g for 5 minutes at
4°C. The wet pellets were stored at 4°C overnight. On the second day HEK cells, which
should be about 80% confluent, were transiently transected with Lipofectamine2000
according to the manufacturer’s protocol for 100 mm dishes, using 27 µg plasmid and
67,5 µl Lipofectamine. After 16-20 hours incubation medium was exchanged to 6 ml
fresh growth medium, which was incubated for another 48 hours, allowing viruses to be
released into the supernatant. This supernatant was collected and filtered through a
0.45 µm filter. Part of it was added freshly to the target cells, the rest was aliquoted and
snap frozen at -80°C. Of note, the virus titer after one freeze-thawing cycle decreases
by about 50%, therefore aliquots were only frozen and thawed once.
One day before viral transduction, the U2OSmcat target cells were plated to a con-
fluency of about 30% in a 35 mm-dish. Before transduction target cells were washed
once with PBS. Then 2 ml growth medium containing the viral supernatant and DEAE
(Diethylethanolamine)-dextran solution at a final concentration of 10 µg/ml was added.
After 3 hour incubation at 37°C 1 ml growth medium was added to the cells. Importantly,
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U2OS cells were most efficiently transduced with small amounts of viral supernatant
(200 µl fresh undiluted supernatant or 500 µl frozen supernatant) rather than with large
amounts. 24 hours after transduction the medium was exchanged and another 24
hours later single cells were sorted by FACS according to the standard protocol. Two
aliquots of unsorted cells were frozen to allow new sorting at a later time point.
2.2.3.3. FACS
Fluorescence assisted cell sorting (FACS) is used for high throughput examining,
counting, and sorting of single cells and is a convenient method to generate single
cell clones of a stable cell line. The flow cytometer detects and analyses physical and
chemical characteristics of single cells in a stream of fluid. Two liquids of sufficient
different velocity or density to not mix, flow through a tube, where they form a two-layer
stable flow, with the sheath fluid enveloping the sample fluid. This produces a very
small sample flow cross-section, where a single cell can pass through the laser beam.
Several detectors are aimed at this point, one in line with the light beam (Forward Scat-
ter; FSC), and several perpendicular to it (Side Scatter; SSC, and one or more fluores-
cent detectors). Each suspended particle scatters the light and fluorescent chemicals
that are bound to or were produced within a cell are excited into emitting light with the
appropriate laser. The FSC correlates with the cell volume, whereas the SSC provides
information about the inner complexity of the cell, i.e. the shape of its nucleus, amount
and type of cytoplasmic granules, or the membrane roughness.
Promoter-luciferase-construct expressing cells were sorted for their healthiness,
meaning that their shape and size were within the range of the normal population and
that cells were propidium iodide negative. The fluorescent molecule propidium iodide,
which was added to the sorting medium, binds with DNA but is membrane impermeant
in viable cells. Therefore it is often used to differentiate dying from viable cells.
Protocol: The sorting medium contained cell dissociation buffer (5%), FCS (0.2%),
propidium iodide (1 µg/ml) and penicillin/streptomycin (1x) and was freshly prepared
and sterile filtered for each experiment. For sorting, cells were trypsinized and cen-
trifuged in 5 ml DMEM growth medium at 200 g and 4°C for 5 minutes. The supernatant
was carefully aspired and sorting medium was added to the cells (500 µl for a 35 mm
dish, 1 ml for a 100 mm dish). After careful resuspension by pipetting three times up
and down, cells were separated by pipetting them through a single-cell filter and sorted
into 96-well plates containing conditioned medium. This medium has been incubated
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with growing cells for a couple of days, was then sterile filtered with a 0.22 µm filter, and
complemented with the same amount of fresh medium. Conditioned medium contains
all grow factors secreted by the cells and preparing and incubating it at 37°C and 5%
CO2 a day before sorting increased survival rates of the cells, achieving viability rates
of about 40%. Moreover, it was important that U2OS cells were not sorted directly after
thawing, but only after about 2 weeks to increase survival rate.
2.2.4. Circadian experiments
2.2.4.1. Real-time bioluminescence monitoring
The firefly luciferase generates light from its substrate D-luciferin in a chemical reaction:
luciferin + ATP→ luciferyl adenylate + PPi
luciferyl adenylate + O2 → oxyluciferin + AMP + light
Luciferase is inhibited by its product oxyluciferin and activated allosterically by ATP.
Moreover, in a side reaction with luciferyl adenylate oxygen is reduced to hydrogen
peroxide.
In cell lines stably expressing promoter luciferase constructs, the expression of lu-
ciferase is under control of the promoter of interest. Circadian activation of the promoter
can be followed through detection of the resulting rhythmic luminescence, as shown for
U2OS BMAL1-luc [4]. Cells in culture desynchronize over time. A medium change
on the day of the measurement was however sufficient to yield consistent rhythms of
luciferase expression in BMAL1-luc U2OS cells. This is probably due to the fact, that
fresh medium contains a higher glucose concentration, as well as a higher concentra-
tion of other growth factors, resulting in a resetting of the clock through a small serum
shock, a known method to reset cells [7].
Protocol: One day before the experiment 30,000 cells/well were split into a white
96-well plate. For optimal results cells needed to be 100% confluent at the time of
starting the measurement. Cells were washed once with PBS and then medium was
exchanged to DMEM (without phenolred) supplemented with FCS (10%), Hepes (25
mM), Luciferin (0.125 µM; P.J.K), and Penicillin/Streptomycin (1x). Medium was sup-
plemented with Hepes to buffer the pH at physiological CO2-concentrations. Cells were
then incubated for 1-2 hours at 37°C and 5% CO2 before sealing them. Measurement
of luminescence occurred every 20-30 min in the EnVision Excite (PerkinElmer) for
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about a week. During this time cells were kept at 37°C, without additional CO2. For
each cell line 8 wells were measured at the same time and constructs were consid-
ered as rhythmic when more than one cell line with repeatable rhythmic expression of
luciferase was produced. Thus obtained data was analyzed using the Multicycle soft-
ware (Actimetrics). Raw data was detrended over the running average of the past 24
hours and smoothened by the software.
2.2.4.2. Time courses
In order to monitor rhythmic changes in the rate of transcription time course exper-
iments were conducted. Expression of target genes was tested using qPCR (time
courses Z1 and Z3) or a combination of qPCR and microarray studies (time courses
Z4 and Z5). Time courses were performed by harvesting cell extracts for two days
every 3-4 hours, yielding 16 or 12 time points, respectively.
Because cells desynchronize over time in cell culture and in order to be able to
compare data from different measurements a precise starting point needed to be es-
tablished, which means that cells needed to be reset by or entrained to a specific
Zeitgeber. Two published methods were used to reset U2OS, one using the glucocor-
ticoid analog dexamethasone (time courses Z1 and Z3) [177, 3] and the other through
entrainment to rhythmic temperature changes (time courses Z4 and Z5) [87, 186]. Glu-
cocorticoids are known as timing cues for peripheral oscillators in vivo and dexametha-
sone was found to be able to entrain circadian rhythms in rat-1 fibroblasts and in the
periphery but not in the SCN. It is therefore believed, that glucocorticoids might partici-
pate in the resetting of peripheral clocks induced by feeding [177, 187]. Environmental
temperature cycles are a universal entrainment cue for all circadian systems at the or-
ganismal level. In homeothermic vertebrates, it was recently shown that although the
SCN can resist temperature entrainment, the peripheral oscillators cannot. It is there-
fore assumed that the SCN drives circadian rhythms in body temperature, which then
act as a universal cue for entrainment of peripheral oscillators [87, 186]. Temperature-
cycles were found to be suitable in U2OS cells (unpublished data). In this work it was
preferably used over dexamethasone, because it yields better rhythms with a slightly
higher amplitude and does not require treatment with a chemical.
Protocol: For resetting cells with dexamethasone cells were grown to confluence.
The growth medium was exchanged to fresh medium containing dexamethasone at
a final concentration of 1 µM. Cells were incubated with this medium for 20 minutes
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at 37°C degrees and then washed with PBS before adding freshly prepared growth
medium.
For temperature entrainment U2OS cells were incubated at alternating 12 h, 33°C
and 12 h, 37°C cycles. Medium changes were carried out at the transition from 33°C
to 37°C. For time course Z5, cells were pre-incubated under temperature entrainment
for 4 days. On day 5, 160,000 cells/well were seeded in 32 x 35 mm dishes, which
corresponds to a confluency of about 16% on the first day. Cells were grown in the
same incubator for 5 more days under temperature entrainment until they reached
confluence. Growth medium was exchanged directly before the cells were released to
constant 37°C. 24 h and 48 h after medium change cells were harvested at 3 h intervals
for 24 h. The time course Z4 was carried out similarly, with the exception that cells were
incubated in two incubators with opposite temperature rhythms and harvested for 12 h
on two days. Cells were harvested in RLT lysis buffer and snap-frozen for later RNA
isolation using the RNeasy kit (Qiagen).
2.2.5. Biochemical methods
2.2.5.1. Protein extracts
Total protein extracts of U2OS cells were prepared for western blot analysis.
Protocol: Cells were trypsinized and cell pellets were either used directly or frozen
at -80°C and thawed for later protein extraction. 100 µl per 35 mm dish of cells were
incubated with RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton-X, 0.25%
Sodium-Deoxycholate, 3 mM EDTA) that was freshly supplemented with protease in-
hibitors (cOmplete, Roche) and phosphatase inhibitors (PhosSTOP, Roche). After vor-
texing for 20 seconds, cells were incubated in an ultrasound bath at 4°C for 10 minutes.
Lysates were centrifuged at maximal velocity for 5 minutes at 4°C. The protein concen-
tration of the supernatant was measured using the NanoDrop and then boiled with the
appropriate amount of 4x Laemmli buffer (250 mM Tris HCl pH 6.8, 6% (w/v) SDS, 40%
(w/v) Glycerol, 0.04% (w/v) Bromphenolblue, 20% β-Mercaptoethanol) for 3 minutes at
95°C.
2.2.5.2. SDS-PAGE and western blot
Protein extracts are commonly separated and analyzed using SDS-PAGE (Sodium-
Dodecyl-Sulfate Polyacrylamide-Gelelectrophoresis) [188]. The combination of SDS-
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PAGE with western blotting allows the detection of specific proteins on the gel [189].
In a SDS-PAGE proteins are separated according to their electrophoretic mobility,
which is a function of both the length of the polypeptide and its charge. Laemmli-buffer
is added to protein lysates. It contains the anionic detergent SDS that adds negative
charges in proportion to the length of the polypeptide. Thereby, proteins on a denat-
urating acrylamide gel are separated mainly according to their size. Electrophoresis
on polyacrylamide gels takes place vertically and the proteins run through two differ-
ent types of gel. The upper portion, the stacking gel, contains pockets and collects
("stacks") all proteins at the border to the lower portion of the gel, the running gel. This
portion can contain variable amounts of acrylamide/bisacrylamide, thereby changing
the pore-size of the gel. In a western blot the separated proteins are subsequently
transferred from the gel to a nitrocellulose membrane using the semi-dry blotting tech-
nique during which an electric current transfers the negatively charged proteins to the
membrane. Proteins bind to the membrane by hydrophobic and charged interactions.
They are detected using antibodies specifically for the proteins of interest. A second
antibody is directed against the species from which the first antibody originated and
coupled to a peroxidase. Proteins are detected by a chemiluminescence reaction car-
ried out by this conjugated peroxidase that oxidizes luminol to emit visible light. Several
secondary antibodies can bind to one primary antibody, thus enhancing the signal. The
incubation with a light-sensitive film on the thus-treated blots leads to the visualization
of the bands.
Table 2.5.: Protocol for the used polyacrylamide gels. Temed and APS were added
at the end because they start the polymerization reaction.
Chemicals Running Gel (10%) Stacking Gel (5%)
Acrylamide (30%)/Bisacrylamide (0.5%) 5.7 ml 0.85 ml
Tris-HCl, pH 8.8 (1 M) 6.5 ml 0.3 ml
H2O 4.5 ml 3.8 ml
SDS (10%) 0.167 ml 0.05 ml
Temed 20 µl 5 µl
APS (10%) 100 µl 25 µl
Protocol: For the experiments 10% gels were made, which effectively separate the
proteins of the desired size of about 60-90 kDa. The protocol for both the separating
and the stacking gels can be found in Table 2.5. Gels were run in SDS-Buffer (60.55
g TRIS, 288.3 g Glycine,100 ml SDS-solution [10% w/v], H2O ad 10 L, pH 6.8) over
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night at 5 mA per gel, and transferred to an Optitran nitrocellulose membrane (BA-
S 85, Whatman) using the semi-dry blotting technique. Whatman-paper (3 mm) and
membrane were soaked in Blot-buffer (24.2 g TRIS, 112.6 g Glycine, 2 L methanol,
80 ml SDS-solution (10%[w/v]), H2O ad 10 L). Three layers of whatman-paper were
placed on the bottom of the blotting chamber, followed by a nitrocellulose membrane,
the gel and another layer of three whatman-paper. Gels were blotted for 2 hours at 300
mA/gel, after which the bands were visualized by Ponceau S solution (0.1% Ponceau
S in 5% acetic acid), a diazo dye that reversibly and unspecifically stains all proteins on
the blot. Staining was used to cut out individual lanes of protein-extracts, which were
later incubated with different antibodies. Blots were first blocked for 45 min at room
temperature with 5% milk powder in TBS (TRIS Buffered Saline) in order to prevent
unspecific binding of the antibody. They were incubated with the first antibody diluted
as indicated in table 2.6 for 2 hours at room temperature. In order to test the affinity-
purified antibodies total extracts were incubated with the pre-immune serum (1:1000),
serum before affinity-purification (1:1000), and the same serum (1:1000) blocked with
the specific peptide (10 µg/ml). After a 4 x 2-minute wash with TBS the secondary
antibody was applied over night at 4°C. The blot was washed 3 x 10 minutes with TBS.
Chemiluminescence detection with a solution containing luminol, p-coumaric acid and
H2O2 was carried out on a light-sensitive film (Fuijifilm SuperRX) .
Table 2.6.: Western blot conditions for peptide-antibodies. The antibodies were
tested for specificity in western blots. Affinity-purified antibodies were
used in the indicated concentrations. The first antibody was incubated
for 2 hours at room temperature or at 4°C over night.
Target protein Dilution 2nd Antibody Signal height
BMAL1 1:750 1:5000 75 kDa
CLOCK 1:300 1:5000 9 kDa
CRY1 1:300 1:5000 60 kDa
CRY2 1:300 1:5000 60 kDa
2.2.6. Molecular biological methods
2.2.6.1. Quantification of RNA and DNA
The concentration of RNA and DNA was determined using the NanoDrop.
For RNA the absorbance ratio at 260 nm and 230 nm was determined. The 260/230
values should be in the range of 2.0 - 2.2. Lower ratios indicate the presence of con-
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taminants which absorb at 230 nm. If the ratio was lower RNA was purified again using
the Qiagen RNeasy Kit. Moreover, the ratio of absorbance at 260 nm and 280 nm was
measured. A ratio of 2 was considered as "pure" for RNA, whereas a ratio of 1.8 was
considered as "pure" for DNA. A lower ratio might indicate the presence of proteins or
other contaminants that absorb strongly around 280 nm.
For the microarray RNA samples were labeled with Cy3 and Cy5 (see Figure 2.8).
The NanoDrop software offers a test type called "MicroArray" which estimates the
amount of both dyes in the sample along with the concentration of the RNA. Value
and purity of the specific dye were assessed and a ratio of pmol dye per µg cRNA was
determined, which was used for calculating the amount of cRNA to be used on the
array.
2.2.6.2. PCR
Table 2.7.: Standard protocol used for all PCR reactions using Finnzymes Phusion
polymerase.
PCR protocol
Repeat Temp (°C) Time
1x 98 30s
28x 98 10s72 30s + 30s/kb
1x 72 180s
hold 4 ∞
Table 2.8.: Standard 1x Mastermix for PCR using Phusion. For all PCRs the High
Fidelity (HF) Master Mix from Finnzymes was used. It contains MgCl2.
1x PCR Mastermix
Volume (µl ) Reagent
10 µl HF buffer
1 µl dNTPs (10 µM each)
100 ng gDNA
0,5 µl Phusion Pol
3% DMSO
ad 50 µl water
The Polymerase Chain Reaction (PCR) was first presented in 1985 by Kary B. Mullis
[190, 191] and contributed so profoundly to today’s scientific work that already in 1993
he received the Nobel Prize for Chemistry for its invention.
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PCR is based on a simple 3-step process during which a specific region of DNA is
amplified. First, the DNA template is denaturated by heat. Next, specific primers, short
DNA templates complementary to the beginning and the end of the amplified region,
anneal to the template. The primers are then extended by a thermostable polymerase.
Each cycle leads to a duplication of the target sequence. After repeating this procedure
multiple times, a high amplification of the region of interest is obtained, which can
be visualized, for example on an agarose gel. Preceded by reverse transcription this
method can even be applied for amplification of mRNA. The basic PCR method has
proven to be useful in order to detect small quantities of DNA in a sample as well as
for amplification of a specific gene.
In this work PCR was used for amplification of the promoter regions for CRY1,
NR1D1, and PER2 from genomic DNA obtained from U2OS cells. For all experiments
Phusion Polymerase (Finnzymes) was used. The basic PCR protocol can be found in
tables 2.7 and 2.8. Primers and PCR-conditions for the constructs are in Tables 2.9
and 2.10. The constructs were first cloned into the pGL3-vector (Promega). This vec-
tor was then used as template for amplification and cloning into the pGL4.20 vector.
The CRY1-promoter was amplified using the same primers in both cases. Because of
already existing restriction sites in the pGL4 vector, primers with new restriction sites
had to be used for NR1D1 and PER2. This did not affect the sequence of the construct.
Table 2.9.: List of primers for cloning. The added restriction site is written in minus-
cule and is preceded by an overhang of bases to allow processing by the
enzyme.
Name Sequence
Cry1_NheI_FWD TTTgctagCCTTGAGAAATCACACTTCAGAGGG
Cry1_HindIII_REV TTTaagcttGCCGACACCTTCGCTTCC
NR1D1_P1_BglII_FWD CCCagatctGGTCGGTCACTTCTCCTAAGCTTCC
NR1D1_P1_NcoI_REV CCccatgGTCTTCACCAGCTGAGAGCGGTC
NR1D1_P1_NheI_FWD CCCgctagcGGTCGGTCACTTCTCCTAAGCTTCC
NR1D1_P1_BglII_REV TTTagatctGTCTTCACCAGCTGAGAGCGGTC
Per2_2_MluI_FWD CCacgcgtCGACCACAGGCACCTCAGAG
Per2_2_NcoI_REV CCccatggGCTCCTGAGCTGCGAAGCG
Per2_SacI_FWD CCgagctcCGACCACAGGCACCTCAGAG
Per2_HindIII_REV GGaagcttGCTCCTGAGCTGCGAAGCG
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Table 2.10.: Sequence and PCR-conditions used for amplification of promoter-
regions. The table shows into which plasmids the inserts were cloned,
which part of the promoter was amplified (bp rel to transcription start
site), the length of the fragment (bp) and which PCR-conditions (temper-
ature and DMSO amount) were used.
Name from ... to Position Length PCR
Cry1_NheI_FWD gDNA to pGL3 -1107 to + 799 1906 69°C
Cry1_HindIII_REV pGL3 to pGL4.20 3% DMSO
NR1D1_P1_BglII_FWD gDNA to pGL3 -858 to + 625 1483 72°C
NR1D1_P1_NcoI_REV 3% DMSO
NR1D1_P1_NheI_FWD pGL3 to pGL4.20 72°C
NR1D1_P1_BglII_REV 3% DMSO
Per2_2_MluI_FWD gDNA to pGL3 -848 to +204 1053 72°C
Per2_2_NcoI_REV 10% DMSO
Per2_SacI_FWD pGL3 to pGL4.20 72°C
Per2_HindIII_REV 10% DMSO
2.2.6.3. Quantitative PCR
Using real-time PCR technology the basic PCR method was expanded for quantitative
measurements as well, called quantitative PCR (qPCR) or real-time PCR. For quanti-
tative PCR a fluorescent probe is added to the PCR Mastermix, which will generate a
fluorescent signal relative to its incorporation into the PCR-amplicon, that can be quan-
tified in real-time during the PCR-run. All probes in this work are fluorescent hydrolysis
probes, which either stem from the Universal probe library (UPL, Roche) or have been
designed specifically and are tagged with the fluorophor 6-FAM (Carboxyfluorescein) at
the 5'end and with the quencher TAMRA (Rhodamine) at the 3'end. Hydrolysis probes
bind within the amplicon generated by forward and reverse primer and only emit a flu-
orescent signal once the quencher is cleaved by the polymerase during the elongation
of the PCR-fragment. The generation of the amplified product is monitored through an
increase in fluorescence after each cycle of amplification. Typically the curve has a
sigmoidal shape, with a flat line at the beginning and the end and a steep rise in be-
tween. Quantification of gene targets on the Roche Light Cycler is based on crossing
point cycle (Cp) values. The crossing point cycle is determined by taking the second
derivative maximum of the generated signal, which corresponds to a point very early in
the amplification process, where amplification occurs in a linear fashion.
Quantitative PCR was performed on the Roche Light Cycler 480 using the Taq-
Man Gene Expression Master Mix from Applied Biosystems. For normal quantifica-
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tion, cDNA was diluted 1:20. ChIP-DNA was eluted in 200 µl after clean-up for direct
use. The enrichment of distinct regions on chromosome 7 was measured with 5 ng
and 50 ng genomic DNA. For preRNA measurements the Fast Advanced Master Mix
from Applied Biosystems was used which provided Cp values 2-4 cycles earlier than
the Gene Expression Master Mix. PCR protocol and mastermix were identical in both
experiments and are listed in Tables 2.11 and 2.12.
Table 2.11.: Standard protocol for the qPCR master mix of one 20 µl reaction. 15 µl
mastermix were prepared and pipetted to 5 µl of sample.
qPCR Mastermix
Volume (µl ) Reagent
10 µl 2x Master Mix
0.2 µl Forward primer (20 µM)
0.2 µl Reverse primer (20 µM)
0.2 µl probe (10 µM)
4.4 µl water
Table 2.12.: Standard protocol used for qPCR-reactions at the Light Cycler 480.
qPCR protocol
Step Repeat Temp (°C) Time
Initial Denaturation 1x 50 2 min95 10 min
Amplification 40x 95 15 s60 1 min
Cooling 1x 37 30s
2.2.6.4. PCR clean-up
The Wizard (R) SV Gel and PCR Clean-Up System from Promega is a membrane-
based system, designed to extract and purify DNA fragments of 100 bp to 10 kb. DNA
binds to silica membranes in the presence of chaotropic salts, allowing other sub-
stances to be washed through the column. DNA was purified from agarose gels after
PCR amplification or restriction digestion as well as directly from solution after ChIP.
Protocol: The protocol for all purifications is similar, but for the first step. When
purifying a DNA fragment from an agarose gel, the gel was run according to standard
procedures. Subsequently the band was excised from the gel and dissolved in the
presence of guanidine isothiocyanate (1 ml membrane binding solution per g of gel)
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Table 2.13.: Primers used for detection of mRNA levels using quantitative PCR.
Primer Name Sequence 5’ - 3’ Probe No
mRNA - probe: UPL
ANKRD12_FWD cgtccagtggatgtagcaga 82
ANKRD12_REV tgagcctcttcggaatctgt
ATG3_FWD aacagtgaccattgaaaatcacc 87
ATG3_REV gattttcttcatcacctcagcat
EIF5A2_FWD ttagcctcggcaaaccaa 60
EIF5A2_REV cttgtgctttagaaatttcctttgt
SCN5A_FWD gagcaacttgtcggtgctg 12
SCN5A_REV gatttggccagcttgaagac
Luc2P_FWD cgcagtaggcaaggtggt 77
Luc2P_REV cagtgtcttaccggtgtcca
18s_rRNA_FWD ttgactcaacacgggaaacc 77
18s_rRNA_REV cgctccaccaactaagaacg
mRNA - probe: 5’ 6-Fam-3’Tamra
HPRT_FWD ctggcgtcgtgattagtgat
HPRT_REV ctcgagcaagacgttcagtc
HPRT_probe caccctttccaaatcctcagcataatg X
GAPDH_FWD catcaatggaaatcccatca
GAPDH_REV gactccacgacgtactcagc
GAPDH_probe tccaggagcgagatccctcca X
BMAL1_FWD ttggacgactgcattctcat
BMAL1_REV aatagctgttgccctctggt
BMAL1_probe tccatctatcgcgtgccgaga X
CRY1_FWD cttgatgcagattggagcat
CRY1_REV ccattgggatctgttctcct
CRY1_probe acagccacatccaacttccagca X
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Table 2.14.: Primers used for detecting introns and ChIP-enrichment using quantita-
tive PCR.
Primer Name Sequence 5’ - 3’ Probe No
pre-mRNA - UPL/5’ 6-FAM-3’Tamra
BMAL1_intron13_FWD ctaggcagtacaagaaccaaaagac 25
BMAL1_intron13_REV gatgaatgtagcttttgggtgac
ANKRD12_intron10_FWD gagcgagtcttctggtttgac 31
ANKRD12_intron10_REV ttctccagtcttccacagttca
ATG3_intron10_FWD ccctctcagttttggcttattct 26
ATG3_intron10_REV cacatggtatcagttggacaaaa
GAPDH_intron4_FWD gtgtccctcaatatggtcctg X
GAPDH_intron4_REV ttctccatggtggtgaagac
GAPDH_intron4_probe tactcagcgccagcatcgcc
qPCR ChIP peak - 5’ 6-FAM-3’Tamra
GAPDH_gDNA_FWD catcaatggaaatcccatca
GAPDH_gDNA REV ttctccatggtggtgaagac
GAPDH_gDNA_probe tactcagcgccagcatcgcc X
PER1_Ebox1,2_FWD agacctctcagcctatgagaaagc
PER1_Ebox1,2_REV cccgacctgccaagattg
PER1_Ebox1,2_probe tggagagcgggactggcatttacg X
PER1_Ebox3_FWD cacagagccctccccttca
PER1_Ebox3_REV ggcactcccctcactgtca
PER1_Ebox3_probe ccttccctcattgttcaggaaagcttaggc X
PER1_Ebox4_FWD catccttcctccacccactc
PER1_Ebox4_REV caaatcctgggagaggacagtta
PER1_Ebox4_probe cccaccggtcacacgtggacc X
Table 2.15.: List of primers used to verify amplification of certain regions on chr 7
using quantitative PCR.
Name Sequence 5’ - 3’ Probe No Position on chr 7
PDGFA_intron2_FWD agtgctggtcttggctctg 43 0.5 Mb
PDGFA_intron2_REV ctgcgagccgtgtttacag
LFNG_peak_FWD ccaggccactgttggaaa 64 2.6 Mb
LFNG_peak_REV gatatggctggtgcctcac
FOXK1_up_chr7_FWD ctccttgatcaggtcccaac 20 4.6 Mb
FOXK1_up_chr7_REV tgtgtgtgttgtgcagtgtgt
EGFR_down_chr7_FWD cctggttcaacacacagctc 37 55 Mb
EGFR_down_chr7_REV ttgtggttctaaaggcgaaac
Serpine1_prom_FWD taacccctggtcccgttc 77 100 Mb
Serpine1_prom_REV caacaaccttgtctggctga
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in a thermocycler at 65°C. The solution was then incubated on the columns. DNA-
fragments that were purified from solution (i.e. after ChIP) were mixed with one volume
of membrane binding solution and incubated directly on the silica columns. After cen-
trifugation at 16,000 g the flow-through was discarded and columns were washed first
with 700 µl wash buffer followed by 1 minute centrifugation, next with 500 µl wash buffer
and 5 minute centrifugation. The empty columns were dried at 1 min maximum velocity
in the centrifuge. DNA was eluted in 30-50 µl prewarmed water.
2.2.6.5. Agarose gel electrophoresis
DNA is a highly negatively charged molecule and can be separated according to its
size on agarose gels. It is then visualized by adding ethidiumbromide to the gel, which
intercalates into DNA and fluoresces when exposed to ultraviolet (UV) light. Agarose
gels are easily cast and electrophoresis takes place horizontally in TAE (TRIS Acetic
Acid EDTA) buffer (4.84 g TRIS, 1.14 g Acetic Acid, 0.744 g Na2EDTA per L). Load-
ing dye (30% glycerol, Bromphenol Blue, and Xylene cyanol) is added to the samples
which increases viscosity and thereby allows pipetting of the sample into the gel pock-
ets. For the DNA-products in this work 1% [w/v] (in TAE) agarose gels were used.
To prepare these gels the appropriate amount of agarose is boiled in TAE buffer and
then stored at 60°C until used. Gels are cast and 1 drop ethidiumbromide is added
and mixed. When the gel cools down it becomes solid. Gels were run in a specialized
chamber filled with TAE buffer at 100 V for 30 minutes or until desired separation has
taken place. For cloning exposure to UV-light must be minimalized in order to prevent
UV-light induced DNA-damage.
2.2.6.6. RNA purification
The RNeasy Kit (Qiagen) was used for extraction of RNA from cell lysates and for
cleaning-up RNA after labeling for the microarray experiments.
Protocol: Cell lysates were prepared by washing cells once with PBS, and then
adding 350 µl RLT buffer to the dish. Cells were then detached using a cell scraper
and pipetted into a tube. This tube was vortexed for 20 seconds, after which the lysate
was sheared by pipetting 10x up and down using a syringe with a 20G-needle. The
resulting lysate was snap-frozen and stored at -80°C until further preparation.
Frozen aliquots were quickly thawed at 37°C and mixed by pipetting after addition
of 1 volume ethanol (70%). The mixture was transferred to an RNeasy column and
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centrifuged for 15 seconds at 10,000 g. The columns were washed first with 700 µl
RW1 and then with 500 µl RPE. A final washing step was carried out with another 500
µl RPE, followed by 2 minutes centrifugation at 10,000 g. The column was then placed
into a new collection tube and dried by 1 minute centrifugation at 16,000 g. The RNA
was eluted with 40 µl RNase free water.
Labeled samples were purified similarly. First, the volume of the sample was ad-
justed to 100 µl with water. Next, 350 µl RLT were added, followed by 250 µl of ethanol
(100%). Then the sample was transferred to the RNeasy column. The same protocol
for purification was used as before, with the exception of starting directly with wash
buffer RPE1.
2.2.6.7. gDNA extraction
The DNeasy Kit (Qiagen) was used for extraction of genomic DNA from cell lysates.
Protocol: First, cells were trypsinized as described before. Cells were taken up
in PBS (2 ml per 35 mm-dish, 10 ml per 100 mm-dish) and centrifuged 5 minutes at
300 g. The pellet was resuspended in 200 µl PBS. Next, the lysate was incubated at
room temperature for 2 minutes with 20 µl Proteinase K (provided) and 10 µl RNase
(Stock conc. 10 mg/ml). Then, 200 µl buffer AL was added to the sample and vortexed
before incubation at 56°C for 10 minutes. Next, 200 µl ethanol (100%) was added and
mixed by vortexing. This lysate was then transferred to a minicolumn and centrifuged 1
minute at 8000 g. The columns were washed first with 500 µl AW1 followed by 1 minute
centrifugation at 8000 g and next with 500 µl AW2 followed by 3 minutes centrifugation
at 20,000 g. The gDNA was eluted after 1 minute incubation with 200 µl buffer AE.
2.2.6.8. cDNA synthesis
For cDNA synthesis the QuantiTect Reverse Transcription Kit (Qiagen) was used. It
comprises two main steps: elimination of genomic DNA and reverse transcription. Re-
verse transcriptase requires primers to initiate the transcription process. The primers
in the supplied RT Primer Mix allow cDNA synthesis from all regions of the RNA
transcripts. Quantiscript Reverse Transcriptase contains an RNA-dependent DNA-
polymerase activity which transcribes cDNA from an RNA template. Moreover, an
RNase H activity of the enzyme specifically degrades the RNA from the RNA:cDNA
hybrids, but has no effect on pure RNA.
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Protocol: 1 µg of RNA was used for preparation of 20 µl of cDNA. The volume
was adjusted to 12 µl and incubated with 2 µl gDNA wipe-out buffer at 42°C for 2
minutes and then placed on ice. The reverse-transcription master mix was prepared
by combining 1 µl Quantiscript Reverse Transcriptase, 4 µl Quantiscript RT buffer (5x)
and 1 µl RT Primer Mix. Template RNA was incubated with the reverse-transcription
master mix for 30 minutes at 42°C. An incubation step of 3 minutes at 95°C inactivated
the reverse transcriptase. The cDNA was diluted 20-fold and stored at -20°C.
2.2.6.9. Cloning
The CRY1-, NR1D1- and PER2-promoters were amplified by PCR from human U2OS
genomic DNA. They were first cloned into the pGL3 vector (Promega) which did not al-
low for selection due to lack of an antibiotic-resistance marker. This plasmid was used
as template for PCR amplification of the constructs for cloning them into the pGL4.20
which harbored a puromycin-resistance. The pGL3-PER2-luc construct was also di-
gested with the enzymes MluI and BamH1 to yield a promoter-luc fragment that could
be cloned into the pSIN_MCS. The promoter-luciferase constructs for ATG3, EIF5A2,
GAPDH, and SCN5A were cloned after restriction digestion from the pSGG plasmid
into the pSIN_MCS-plasmid.
Protocol: The promoters were amplified with PCR and purified using the PCR clean-
up kit as described in the PCR-section. All of the purified PCR-constructs and 2-4 µg
vector were then digested at 37°C for 2-3 hours with the restriction enzymes (NEB).
Amounts of enzymes were calculated based upon their activity and the data given in the
NEB catalog. In order to prevent religation of the vector the 5'-phosphate was removed
by 30 minutes incubation at 37°C with 1 µl CIP (Calf-Intestinal Alkaline Phosphatase).
After digestion the constructs were purified directly by a PCR clean-up column, while
the vector was run on a 1% agarose gel before the appropriate band was dissected
from the gel and purified using the PCR clean-up kit. Ligation reactions were prepared
using 50 ng vector and 3x and 9x the amount of insert, as estimated by the DNA-
concentration and taking into consideration the varying molecular weight. Per 20µl
reaction 2 µl 10x Ligation buffer (Fermentas), 1µl vector and 1µl ligase (Fermentas)
were combined. Ligation occurred for 1 hour at 22°C. Half of the reaction was then
transformed into competent E.coli DH5α or E.coli XL1-blue cells according to the pro-
tocol and plated out on LB-ampicillin (LB-Amp) agar plates (final conc. Amp 100 µg/ml)
that were incubated at 37°C over night. From each plate 3-6 colonies were picked and
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incubated over night in a 3 ml LB-Amp (final conc. Amp 100 µg/ml) liquid culture. From
these cells plasmid preparations were done according to the protocol. These plasmid
preparations were test-digested in a 15 µl reaction containing 4 µl plasmid and 0.25
µl of each restriction enzyme. Half of the reaction was loaded on a 1% agarose gel.
When the digested fragment matched the expected height the fragment was purified
using the PCR clean-up kit and the entire insert was sequenced (GATC, LGC) before
generation of stable cell lines.
2.2.6.10. Transformation of competent cells and retransformation
Transformation is a process by which bacteria take up extracellular DNA, that will sub-
sequently be replicated in each cell division. For transformation to happen, bacteria
must be in a state of competence, for example as a response to environmental con-
ditions. In the laboratory, competent E.coli strains are prepared by incubation in a
solution containing divalent cations, which makes them take-up plasmids after a heat-
shock to 42°C.
Protocol: Competent E.coli cells were stored in 50 µl aliquots at -80 °C. For transfor-
mation, cells were thawed on ice for 5-10 minutes. Then, about 25 ng plasmid from lig-
ation or 200 ng purified plasmid for retransformation, were added to the cell suspension
and incubated on ice for 30 minutes. Next, cells were driven to take up the plasmids by
heat-shock through a 75-second incubation at 42°C, with a subsequent incubation at
4°C for at least 3 minutes. After re-transformation of purified plasmids, the E.coli cells
were directly transferred to a liquid culture of LB-Ampicillin. However, after ligation and
transformation cells were first incubated at 37°C for at least 3 rounds of replication (1-2
hours) in 950 µl SOCS medium without antibiotics. Cells were then centrifuged for 30
seconds at 13,000 rpm and most of the supernatant was discarded. About 50-100 µl
were retained to resuspend cells and plate them on LB-Amp agar plates, which allows
for picking single colonies that contain identical copies of the same plasmid.
2.2.6.11. Purification of plasmids
Protocol Mini Prep precipitation: For small-scale plasmid purification after cloning a
2 ml overnight-culture of E.coli cells was centrifuged for 2.5 min at 13,000 rpm. The
pellet was resuspended in 300 µl resuspension buffer S1 (50 mM Tris-HCl, 10 mM
EDTA, 100 µg/ml RNaseA; pH 8). After addition of 300 µl lysis buffer S2 (200 mM
NaOH, 1%SDS) the tubes were inverted 5x and incubated for 3 minutes. Then, 300
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µl neutralization buffer S3 (2.8 M KAc, pH 5.1) was added, the tubes were inverted 5x
and incubated for another 3 minutes. The lysed cells were centrifuged for 10 minutes
at 13,000 rpm. 800 µl of the supernatant was added to 600 µl isopropanol and mixed
well. After subsequent 15 minutes centrifugation at 13,000 rpm the pellet was washed
with 500 µl ethanol (70%) and centrifuged for another 5 minutes at 13,000 rpm. The
supernatant was discarded and the pellets were dried and resuspended in 50 µl water.
The plasmids were tested for integration of the construct using test digestion. When
the digestion looked as expected the plasmids were purified using the PCR clean-up
kit and subsequently sequenced.
Protocol Midi Prep columns: Plasmids where the insert was verified by sequencing
were prepared in a larger scale and purified by Midi Prep columns (NucleoBond) using
the buffers as before. Briefly, 50 ml overnight culture were pelleted by centrifugation
at 4500 g for 30 minutes. The pellet was resuspended in 4 ml buffer S1, lysed in 4 ml
buffer S2 and neutralized in 4 ml buffer S3, as described above. In the meantime a
column was equilibrated with 2.5 ml buffer N2 (100 mM Tris-HCl, 900 mM KCl, 0.15%
Triton X-100, 15% EtOH, pH 8.5). The lysate was clarified by filtration and then loaded
onto the NuceloBond column. The column was washed with 10 ml buffer N3 (100 mM
Tris-HCl, 1.15 M KCl, 15% EtOH, pH 6.3). DNA was eluted with 5 ml buffer N5 (100
mM Tris-HCl, 1 M KCl, 15%EtOH, pH 8.5). 3.5 ml room-temperature isopropanol was
added and mixed carefully to precipitate the eluted DNA. The mix was centrifuged at
15,000 g for 30 min at 4°C. The pellet was washed with 2 ml room-temperature ethanol
(70%) and dried for 15 minutes. It was redissolved in 200 µl water.
2.2.7. ChIP-sequencing
Chromatin-Immunoprecipitation (ChIP) is a powerful technique for evaluating interac-
tions of transcription factors and DNA-associated proteins with the DNA. Figure 2.6
displays the important initial steps of ChIP. First, all proteins are crosslinked to the
DNA through a chemical agent like formaldehyde. Next, lysates are prepared and the
chromatin is sheared to small fragments of about 200-500 bp length using ultrasound
sonication. DNA-fragments bound by the protein of interest are then immunoprecipi-
tated through beads that are covered with an antibody specific against the protein of
interest. These DNA fragments are then eluted and purified. Enrichment of specific
sequences in comparison to the input is tested using qPCR.
Many advances using this method have been made after the invention of high-
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Figure 2.6.: Overview over chromatin-immunoprecipitation (ChIP). Schematic repre-
sentation of a cell (1). For ChIP proteins were crosslinked to DNA us-
ing formaldehyde (2). Next, cell lysates were sonicated to shear DNA
into small fragments of about 200-500 bp (3). Beads covered with an
antibody specific against the protein of interest were incubated with the
lysate (4) in order to enrich and precipitate specifically all DNA-fragments
bound by this protein (5). The DNA-fragments are eluted from the beads
and purified (not shown).
throughput genome-wide sequencing, so-called "deep sequencing". When ChIP-
samples are sequenced on a high-throughput scale enriched DNA-regions, and thus,
binding sites for the protein of interest, can be assigned on a genome-wide scale.
Several techniques for deep-sequencing have evolved in the past. In this work deep
sequencing was performed using the Illumina sequencing-by-synthesis (SBS) technol-
ogy (Figure 2.7), the bases of which have been developed by S. Balasubramanian
and D. Klenerman in the mid-1990s [192]. The basic concept of SBS is that clusters
of DNA fragments are sequenced during amplification of the complimentary strand
through addition of one nucleotide at a time and subsequent monitoring. First, indi-
vidual short DNA fragments are bound via adaptors to a solid phase, where they are
clonally amplified to produce several million dense clusters of double-stranded DNA.
Then, the complimentary strands to these clusters are synthesized. For this, reversible
fluorescent terminator nucleotides in four colors (one per nucleotide) are added dur-
ing amplification. The terminator sequence allows addition of only one nucleotide to
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1. Prepare genomic DNA sample
Randomly fragment genomic DNA 
and ligate adapters to both ends of 
the fragments.
2. Attach DNA to surface 3. Bridge amplification
4. Fragments become 
    double stranded
Bind single-stranded fragments 
randomlyto the inside surface of 
the flow cell channels.
Add unlabeled nucleotides and 
enzyme to initiate solid-phase 
bridge amplification.
5. Denature the double- 
    stranded molecules 6. Complete amplification 7. Determine first base 8. Image first base
The enzyme incorporates nucleotides 
to build double-stranded bridges on 
the solid-phase substrates.
Denaturation leaves single-stranded 
templates anchored to the substrate.
Several million dense clusters of 
double-stranded DNA are generated 
in each channel of the flow cell.
First chemistry cycle: to initiate the first 
sequencing cycle, all four labeled 
reversible terminators, primers and 
DNA polymerase enzye are added to 
the flow cell.
After laser excitation, the image of 
emitted fluorescence from each cluster 
on the flow cell is captured and the 
identity of the first base for each 
cluster is recorded.
10. Image second chemistry cycle9. Determine second base
11. Sequence reads over multiple
      chemistry cycles 12. Align data
Second chemistry cycle: to initiate the 
next sequencing cycle, all four labeled 
reversible terminators and enzyme are 
added to the flow cell.
After laser excitation, the image data 
is collected as before and the identity 
of the second base for each cluster is 
recorded.
Cycles of sequencing are repeated to 
determine the sequence of bases in a 
given fragment a single base at a time.
Data is aligned, compared to a 
reference, and sequence differences 
are identified.
Figure 2.7.: Overview over the Illumina sequencing process. Explanations as given
in the figure. Figure adapted from the Illumina-Systems and Software
Manual.
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a DNA-strand. After addition of the nucleotide the fluorescent signal emitted by each
cluster of amplified DNA fragment is measured. Then, the next nucleotide is added
to the DNA strands, followed by a new recording of the emitted signal. Sequence
reads over multiple cycles of nucleotide-additions allow determination of the sequence
of the given fragments. On the Illumina Genome Analyzer IIx about 38 bases from
each strand from about 16 million clusters can thus be sequenced, resulting in the se-
quencing about about 1.2 Gigabases (roughly one third of the human genome) which
are then aligned to the genome to identify the sequenced region. Through refinement
and optimization the 2011 generation of Illumina SBS technology-based instruments
generates up to 600 Gigabases per run, sequencing up to 55 Gb per day.
2.2.7.1. ChIP-protocol
ChIP was performed with antibodies against BMAL1, CLOCK, and CRY1 in confluent
desynchronized U2OS cells. Cells were grown for at least 5 days in 100 mm dishes
until they reached confluence in order to avoid any bias due to rhythmicity or the cell
cycle on the cells. The protocol was adjusted and optimized from a protocol published
on the web page of Abcam [193] and was then first published in mouse ChIP-seq ex-
periments with our collaboration partners [5].
Protocol: 10 x 100 mm-dishes were sufficient for 4 ChIPs with enough material for
one sequencing run. First, proteins were cross-linked to DNA by incubating them for
10 min at room temperature with formaldehyde (final conc. 0.4%). Cross-linking was
stopped by a 5 minute incubation with glycine (final conc. 125 mM). Then cells were
rinsed twice with cold PBS and lysed in 500 µl FA lysis buffer (50 mM Hepes-KOH pH
7.5, 140 mM NaCl, 1 mM EDTA pH 8, 1% Triton X-100, 0.1% Sodium Deoxycholate,
0.1% SDS; freshly supplemented with 10% cOmplete) per dish. Next, chromatin was
sheared using a conventional sonicator with a MS72 sonotrode which was introduced
into the sample for a total of 6 minutes at 50% output. The ultrasound was pulsed 12
times for one minute at 1 second on, 1 second off. After each minute a cooling time of
30 seconds was allowed. The entire sonication process was performed in an ice bath.
1 ml was sheared at a time.
The sonicated lysates were centrifuged for 10 min at 8000 g at 4°C. After this, sam-
ples were snapshot-frozen and stored at -80°C. One freeze-thaw cycle did not de-
crease ChIP-efficiency. Protein A Sepharose-Beads CL-4B were used for immunopre-
cipitation. Beads were washed 3x with RIPA buffer and then taken up in the corre-
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sponding volume of RIPA buffer containing 10% 20x Protease Inhibitor (cOmplete). In
order to rid the lysate from everything that would unspecifically bind to the beads, a
pre-clearing step was carried out. 60 µl beads were incubated with the lysate for 1.5-2
hours at 4°C. After incubation the beads were centrifuged for 2 minutes at 1500 g. The
protein concentration of the sheared supernatant was estimated using the NanoDrop.
For the ChIP 25 mg protein lysate were used and 2 mg of protein were stored as input
control. Next, the antibody was bound to the proteins in the supernatant during 3-5
hours incubation on the rotating wheel at 4°C. For the BMAL1 ChIP 4 µl affinity purified
antibody were used, and for the CLOCK and the CRY1 ChIP 16 µl . After overnight
incubation on a rotating wheel with 60 µl beads suspension the protein-antibody-beads
conjugates were precipitated at 1500 g for 2 minutes. The pellet was washed 3 times
with 1 ml ChIP wash buffer. After the first wash the beads were transferred to a new
tube in 300 µl ChIP wash buffer in order to rid the sample of DNA unspecifically bound
to the tube wall. The remaining beads were transferred with another 700 µl wash
buffer. The fourth wash was performed in 1 ml ChIP final wash buffer which provided
more stringent wash conditions through higher salt concentration. After this the super-
natant was carefully taken off with a hamilton-pipette and discarded. DNA was eluted
by incubation with 120 µl ChIP elution buffer for 15 min at 30°C, shaking at 900 rpm.
Beads were centrifuged for 2 minutes at 2000 g and the supernatant was transferred
to a new tube. Decrosslinking was performed with the ChIP-eluate and the input in the
same fashion. The SDS concentration of the input was adjusted to 1%. Cells were first
incubated for 1.5-2 hours at 37°C with RNase (4 µg per 120 µl volume) and then at
65°C with Proteinase K (100 µg per 120 µl volume) shaking for at least 5 hours.
The de-crosslinked DNA was purified using the PCR clean-up kit according to the
manufacturer’s protocol. First, the corresponding volume of membrane binding solution
(120 µl for the ChIPs) was added to the eluate and then incubated on a silica column
for 1 minute and centrifuged down for 1 minute at 16,000 g. Washes were carried out
with 700 µl and 500 µl membrane wash solution followed by 1 minute and 5 minutes
centrifugation, respectively. DNA was eluted after 1 minute incubation with 100 µl
prewarmed RNAse-free water.
Before sequencing ChIPs were tested for enrichment using quantitative PCR. For
this the DNA solution was diluted with 100 µl RNAse-free water and 5 µl per reaction
were used as a template.The enrichment of ChIP samples was compared to the input
using a primer/probe set for GAPDH genomic DNA and a region containing two E-
boxes in the PER1 promoter. Primers used for testing ChIP-enrichment in qPCR are
listed in Table 2.14.
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2.2.7.2. Deep-sequencing
For each ChIP several samples were prepared and only those with the best enrich-
ment, as tested at the PER1 promoter, were used for sequencing. Immunoprecipitated
chromatin (10 ng DNA of 8 independent BMAL1 ChIPs with enrichment levels > 80-
fold, 9 ng DNA of a CRY1 ChIP with 10-fold enrichment, and 8 ng DNA of a CLOCK
ChIP with 40-fold enrichment) was used for deep sequencing at the Lausanne Ge-
nomic Technologies Facility, Switzerland. Sequencing libraries were prepared using
the ChIP-seq Sample Preparation Kit (Illumina) according to the protocol supplied with
the reagents. Products were quantified using the Qubit fluorometer (Invitrogen). Three
lanes of the BMAL1 library, and one lane each of the CRY1 and CLOCK library were
sequenced on the Illumina Genome Analyzer IIx using either Single-Read Cluster Gen-
eration Kit and 36 Cycle Sequencing Kit v2. Data were processed using the Illumina
Pipeline Software v1.40. As a standard control lane a genomic DNA library made with
PhiX DNA was included, which was used to set the base calling parameters used by
the Illumina software for all of the lanes of the flow cell, regardless of the library type.
2.2.7.3. ChIP-seq data analysis
Sequenced DNA reads (Illumina, 38 bases long reads) were mapped to the human
genome (Homo Sapiens Genome Reference Consortium Human Build 37 [GRCh37/
hg19; Feb. 2009]) using Bowtie [194] with maximally two mismatches and only one
hit allowed on the genome. If several reads from the same library mapped to the very
same genomic position and on the same strand, they were considered redundant tags
because they might have resulted not by ChIP, but rather by the amplification process
during library preparation. Thus, from redundant tags only one read was kept for the
rest of the analysis, resulting in 52 million tags for the BMAL1-ChIP, as well as 2.4
million tags for the CLOCK-ChIP and 5.3 million tags for the CRY1-ChIP. Each lane of
the BMAL1 ChIP-Seq yielded 1.6x107 reads, the CLOCK ChIP-Seq 2.1x107, and the
CRY1 ChIP-Seq 2.5x107.
For each protein separately, BMAL1 or CLOCK or CRY1-bound regions were de-
tected by MACS [195] with the following parameters: shift = 70 bp (BMAL1), 90 bp
(CLOCK) and 100 bp (CRY1), bandwidth = 2 x shift, genome size = 2.16 Gb, and an
input chromatin sample from human 293T HEK cells as control data. This yielded a to-
tal of 9459 regions bound by at least one protein. A refined estimate of the binding site
location in each of these regions was then obtained by a deconvolution algorithm that
models the expected distribution of tags on the positive and negative strands [5]. This
2.2 Methods 59
was done separately for each protein in order to accurately detect the genomic location
of the bound protein. For the rest of the analysis, local maxima in the deconvoluted sig-
nal were used as the center positions of the binding sites. The deconvolution methods
also provides a goodness of fit score that quantifies whether the plus and minus tag
distributions fit the expected patterns [5]. This score was used to reject spurious sites.
The binding sites were then attributed a score that combines the enrichment in tag
counts in window of ± 100 bp around their center compared to input chromatin, as well
as the goodness of fit criterion. Of note, sites that overlapped within a 200 bp region,
were extended to cover a larger region, thus resulting in some sites that are longer
than 200 bp. The overlaps between the binding sites of the three proteins were com-
puted using the command "intersectBed" from the BedTools suite [196]. Each binding
site was annotated with the RefSeq gene having the closest TSS. Visualization of the
ChIP-seq and of the detected binding sites for each protein can be found on the UCSC
genome browser:
DNA sequences in the binding sites were retrieved from the UCSC Genome Browser
database. In order to analyze the E-box composition of binding sites, the sequences
for all binding sites were scanned with a weight matrix describing a perfect, highly po-
larized E-box (probability of 0.97 for each base of the motif and probabilities of 0.01
for the 3 other bases). To compute the spatial correlation in the positions of E-boxes,
the likelihood scores returned by the E-box scanning were used and converted into
occupancies using a sigmoid transformation with threshold corresponding to two mis-
matches. The correlation signal was then computed on the occupancies. The enrich-
ment for tandem E-boxes was tested by re-scanning the binding sites sequences using
a weight matrix describing 2 perfect, highly polarized E-boxes joined by 6 unspecific
(background frequencies) bases.
2.2.8. Microarray
In order to test the obtained binding sites for functionality, gene expression was as-
sayed in large scale on a microarray.
2.2.8.1. Array design
A 60k customized microarray was designed for 6356 genes, which corresponds to
about one fourth of the human transcriptome. For each gene 10 different probes were
used to increase reliability of the data. The median signal of all significant probes was
employed for data analysis. The probes were specific for 1373 genes found closest
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to a ChIP-seq binding site. For control two sets of genes without binding sites were
tested. One set contained 3480 completely random genes, whereas the other set
consisted of 1503 specifically selected genes. This latter category was made up of a
large set of genes that seemed potentially to be rhythmic, i.e. 443 genes from ChIP-
sequencing that were not the closest gene to a binding site but within ± 20 kb of it, 78
genes that included BMAL1, NPAS2, casein kinases and nuclear receptors, 449 genes
that were most rhythmic in a previously published microarray analysis in U2OS cells
[3] (modified supplementary data), 93 genes that were differentially regulated through
RevErbα knockout, 83 genes involved in the cell cycle, 90 genes related to epigenetic
regulation, and 83 and 79 genes related to glucose metabolism and oxidative stress,
respectively.
2.2.8.2. Microarray sample preparation
Two 48-hour time courses (Z4 and Z5) were performed as described and cell pellets
were harvested every 3 hours. RNA was purified and samples were labeled with the
Two-Color Low Input Quick Labeling kit (Agilent) according to the provided protocol.
Labeling using two colors allowed a comparison of RNA amounts from each of the 16
time points (labeled with Cyanine-5 (Cy5)) to the average of all 16 time points (labeled
together with Cy3). The signal for Cy5 was set in relation to the signal from Cy3 (sam-
ple relative to average). An internal fluorescent control was provided by adding Spike
A and Spike B to the samples. A schematic overview over the procedure is given in
Figure 2.8.
Protocol: After RNA-extraction RNA dilutions of 66.6 ng/µl were prepared. In the
first step 2 µl of spike A or spike B mix were added in a 1:25600 dilution to 100 ng
(1.5 µl) of each RNA sample. These dilutions were prepared in a 4-step serial dilution
(1:20, 1:40, 1:16, 1:2) as described in the protocol. In the second step, the labeling
reaction was prepared and cDNA was transcribed from the RNA. First, 1.8 µl of T7
Promoter Primer Mix was added to the RNA-samples. The T7 promoter primer is an
Oligo dT-primer that binds to poly A tails of RNA and tags them with an additional T7-
promoter. This mix was denaturated by incubating it at 65°C for 10 minutes, followed by
a 5-minute incubation at 4°C. 4.7 µl of the cDNA Master Mix, containing AffinityScript
RNase Block mix were added to each sample, which was then incubated at 40°C for
2 hours. During this step a complimentary DNA-strand (cDNA) was produced. An
incubation at 70°C for 15 minutes inactivated the Affinity script enzyme. The entire
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sample was placed on ice for 5 minutes.
Figure 2.8.: Schematic overview of cRNA-labeling for the microarray as provided by
the manufacturer (Agilent). The procedure is described in the text.
Next, 6 µl of the T7 RNA polymerase Transcription Master Mix were added to the
samples, which were then incubated for 2 hours at 4°C during which T7 RNA Poly-
merase replaced the complimentary DNA strand with a complimentary RNA strand
(cRNA) at the same time incorporating Cy3- or Cy5-labeled CTP. In the third step the
labeled RNA was purified using the Qiagen RNeasy mini spin columns as described.
The RNAs were eluted in 30 µl RNase-free water and quantified using the Microarray
Measurement tab in the NanoDrop software. The concentrations of cRNA (ng/µl) and
Cy3 or Cy5 (pmol/µl) were used to determine the specific activity of either Cy3 or Cy5
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per µg cRNA. For hybridization to the microarray 300 ng Cy3-labeled cRNA and 300
ng Cy5-labeled cRNA time point-average were combined in the fragmentation mix and
incubated at 60°C for exactly 30 minutes to fragment the RNA. After cooling on ice
25 µl cRNA from the fragmentation mix were complemented with the same volume of
2x GE Hybridization buffer HI-RPM. After spinning them down the samples were im-
mediately loaded onto the microarray and hybridized for 17 hours at 65°C rotating at
10 rpm. After hybridization the array was washed twice for 5 minutes in acetonitrile,
several times shortly with Milli-Q water, 1 minute in GE Wash Buffer 1, and 1 min with
GE Wash Buffer 2 which had been prewarmed to 37°C. Then the slides were put into
a slide holder and scanned immediately.
2.2.8.3. Microarray data analysis
After rejecting probes with too low absolute hybridization signals (less than 20 fold of
the median signal of negative control probes), the raw ratio data of the two independent
48 h time courses was analyzed. Genes with less than two valid probes were rejected
from the analysis. For each gene, the median ratio of all remaining probes was then
used as relative expression measure of one probeset at each time point. For the iden-
tification of rhythmic probesets, the Fisher test was used as described [5, 197]. To be
stringent the following combined filters were used: the Fisher test p-value needed to
pass a threshold of a FDR (False Discovery Rate) [198] of 20% in at least one of the
two arrays, and of 50% in both arrays; the amplitude needed to be higher than 0.25 in
log2 scale on both arrays, which corresponds to a 1.2-fold change from peak to trough;
given that the signal for one gene consisted of the median of at least 3 probes and at
most 10 probes, sufficient correlation between these probes was ensured by requiring
that the temporal average of the standard deviation between the probes does not ex-
ceed 33% of the amplitude of the median signal; the phase of a given gene needed to
be comparable in both arrays, allowing for a deviation of ± 3 h between both arrays.
Together, this analysis yielded a set of 118 robustly rhythmic transcripts.
3. Results
3.1. Circadian regulator binding site analysis
3.1.1. Sequencing
Three lanes of the BMAL1 ChIP and one lane each of the CLOCK- and the CRY1 ChIP
were sequenced. In each lane of the BMAL1 ChIP about 16 million clusters passed
the filter, which corresponds to the number of sequence tags that were obtained. From
the CLOCK- and the CRY1 ChIP 21 and 25 million clusters, respectively, passed the
filter (Table 3.1).
Table 3.1.: Information on sequenced reads. Of note: BMAL1-ChIP was sequenced
on three lanes, whereas the CLOCK-ChIP and the CRY1 ChIP were se-
quenced on one lane each.
ChIP Read Length Loading conc. Pass Filter Clusters
(bp) (pM) (million)
BMAL1
38 12 16
38 12 16
38 12 16
CLOCK 38 10 21
CRY1 38 10 25
3.1.2. Binding site annotation
Circadian regulator binding sites (CRBSs) were annotated as described in detail in the
methods section. During the sequencing process 38 bp were sequenced from the 5'-
end of both, the leading and the lagging strand of the DNA-fragment. This should yield
sequencing profiles for both strands that are similar but slightly offset to one another.
Reads from each strand were mapped separately to the human genome and binding
sites were detected for each ChIP-seq individually using several algorithms taking into
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consideration the shape of the peaks on each DNA-strand. Finally, the binding sites
were extended to a window of ±100 bp and attributed a score which correlated with
the enrichment of reads and with the agreement to the expected distribution on both
strands. This analysis yielded a total of 3040 CRBSs, 2048 of which were bound by
BMAL1, 787 by CLOCK, and 1063 by CRY1. All binding sites were mapped on the
UCSC genome browser and annotated to the closest gene, resulting in a total of 1454
genes with CRBSs. Among these, 956 genes had only one binding site, whereas the
remaining 498 genes harbored 2084 sites. Most known clock-controlled genes, such
as PER1, PER2, PER3, CRY2, NR1D1, DEC1, DEC2, DBP, and TEF possessed 2-4
binding sites, whereas CRY1 and NR1D2 had only one. All these known circadian
genes had at least one common site for BMAL1 and CLOCK binding, in most cases
even for BMAL1, CLOCK, and CRY1. The ability to detect binding at the known clock-
controlled genes shows that the data analysis was reliable.
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Figure 3.1.: UCSC browser views of BMAL1, CLOCK, and CRY1 occupancy at the
promoters of CRY2 (left) and EIF5A2 (right). Each black dot represents
one sequenced read. Data was scaled as indicated on the left of each
ChIP-representation. Regions detected as binding sites of the individual
transcription regulators are marked by colored bars. Black bars show
common CRBSs of the three regulators. In both examples the peaks are
close to the transcription start site.
Two examples of ChIP-seq data with binding sites for all three transcription factors,
as presented on the UCSC genome browser, are shown in Figure 3.1. The left panel
displays the alignment of sequenced tags around the Transcription Start Site (TSS)
of the known clock-controlled gene CRY2, while the right panel shows the alignment
around the TSS of EIF5A2, a gene that was so far not known to be regulated by the
circadian clock. CRY2 contains a second BMAL1 peak downstream of the gene (pink
bar). Although it looks like there could be some enrichment from the CLOCK- and the
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CRY1-ChIP as well, this example demonstrates, that the parameters for detecting a
peak were relatively stringent in order to reduce the amount of false positives and that
in this case either the enrichment or the shape of the second peak for CLOCK and
CRY1 must have been below the set parameters for peak detection.
3.1.3. Distribution of CRBSs
The binding sites for the individual clock proteins showed highly significant though
imperfect overlap (Figure 3.2). The overlap between BMAL1 and CLOCK (214 CRBSs)
as well as between all three ChIPs (179 CRBSs), altogether accounted for 13% of the
binding sites. Of note, about 50% of the CLOCK binding sites overlapped with BMAL1,
whereas only 19% of BMAL1 binding overlapped with CLOCK. About 44% of the CRY1
CRBSs overlapped with sites for BMAL1 and/or CLOCK.
1495 214
17950%
7%
6%
(2048) (787)
(1063)
BMAL1                                    CLOCK
CRY1
160 126
598
5% 4%
9%
19%
268
Total: 3040 CRBSs
Figure 3.2.: Venn diagram showing numbers and percentage of individual and over-
lapping binding sites of BMAL1, CLOCK, and CRY1. The total number of
binding sites is given in parenthesis under the name of each ChIP-seq,
percentages represent the fraction of the CRBSs over the total number
of sites for the three proteins.
3.1.4. Localization of binding sites
Binding sites showed a pronounced enrichment at transcriptional start sites, with 14.6%
within 1 kb of a TSS, suggesting a role in gene expression. In contrast, a simulated
random set of binding sites provided only 0.1% within 1 kb of a TSS (Figure 3.3 top
panels). Individual analysis of the three ChIP-seq data sets (Figure 3.3 bottom pan-
els) showed a strong accumulation for BMAL1 and CLOCK at the TSS, while CRY1
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was only weakly enriched there. Notably, the strongest enrichment around the TSS
occurred at common sites between two or all three ChIPs. Binding sites detected for
BMAL1 only were also highly enriched at the TSS, whereas CLOCK-only binding sites
displayed a broader distribution. CRY1 sites that coincided with binding for BMAL1
and/or CLOCK showed a slight enrichment around the TSS, whereas CRY1-only bind-
ing sites were randomly distributed.
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Figure 3.3.: Binding sites for BMAL1 and CLOCK, but not for CRY1, were highly en-
riched around the transcription start site (TSS). Upper panel left: His-
togram of the distance between two consecutive CRBSs (black) in com-
parison to a set of 3040 random sites (red). Upper panel right: CRBSs
cluster near TSSs. Histograms of positions of all CRBSs are shown for a
window of ± 20 kb around TSSs with a bin size of 200 bp. The numbers
of CRBSs upstream and downstream of the TSS are indicated. Bot-
tom panels: Histograms of individual regulators (bin size 1 kb) show that
CRBSs for BMAL1 and CLOCK are enriched at the TSS. The black line
in each plot marks the distribution of binding sites found only for the re-
spective protein. Common CRBSs for two or all three regulators are most
strongly enriched around the TSS suggesting a relation to transcription.
This enrichment is less for binding sites found for CLOCK only and es-
sentially absent in CRY1-only binding sites.
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The vast majority of CRBSs was located in intergenic regions (49.3%) and introns
(28.4%), 7.5% of the CRBSs were in promoters, 10.0% in 5'-UTRs, 2.3% in exons and
2.4% in 3'-UTRs (Figure 3.4). However, when taking into consideration that intergenic
regions and introns make up 64.1% and 27.1% of the genome, respectively, while the
contribution to the genome of promoters (0.6%), 5'-UTRs (4.8%), exons (1.8%) and
3'-UTRs (1.9%) is considerably small, CRBSs were slightly under-represented in inter-
genic regions (0.8x) and highly enriched in promoters (12.1x) (Figure 3.4, right). They
were slightly enriched in 5'-UTRs (2.1x), but occurred approximately at the expected
rate in exons (1.3x), introns (1.1x) and 3'-UTRs (1.3x). The enrichment in 5'-UTRs re-
flects the general tendency of CRBSs to accumulate in a narrow region of about ± 1
kb around TSSs.
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Figure 3.4.: Location of binding sites. The pie chart (left) shows the percentage of
binding sites in a genomic region (black) and the contribution of the re-
gion (%) to the genome (grey). The bar chart (right) displays the relative
enrichment of CRBSs in a genomic region. CRBSs are highly enriched
in promoters. The center of a binding site was assigned to its localiza-
tion in the gene: promoter (-1 kb to TSS), 5'-UTR, exon, intron, 3'-UTR,
intergenic.
3.1.5. Binding motif analysis
It was published, that in the mouse BMAL1 and CLOCK bind as a heterodimer to E-
boxes or tandem E-boxes with a spacer of 6 or 7 nucleotides [5]. Binding motif analysis
on the dataset from this work supports these findings in humans as well. The E-box
motif with the consensus sequence CACGTG, was highly enriched among the binding
sites (9.8-fold). Interestingly though, the sequence logo for the consensus sequence
(Figure 3.5 upper panel) suggested, that among the E-box motifs in the CRBSs the
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Figure 3.5.: The E-box motif was enriched in BMAL1- and CLOCK-, but not in CRY1-
binding sites. Top panel: CRBSs with imperfect E-boxes (1 mismatch)
display preferential mismatches at the central positions. The logo shows
average proportions of bases. Bottom panel left: Fraction of CRBSs
containing the indicated E-box motifs (black). To control for bias due
to sequence composition, the sequences were randomly shuffled and
analyzed similarly (grey bars). The three main variants cover 43% of
all CRBSs. Bottom panel right: Fractions of CRY1-only sites (light grey
bars, n = 598) and BMAL1 and/or CLOCK sites (dark grey bars, n =
2442) containing the indicated E-box motifs.
central positions were less conserved. Therefore the fraction of sites containing E-
boxes with mismatches in these positions was calculated (Figure 3.5 bottom panel
left). In order to not produce a strand-related bias because the canonical E-box is palin-
dromic, whereas E-boxes with one mismatch are not, the (+)-strand was examined for
the binding motif as well as for its reverse complement. Interestingly, a similar amount
of CRBSs harbored an E-box (22%) as the motifs CATGTG and CACATG (19%), an
E-box with a pyrimidine-to-pyrimidine- or a purine-to-purine-exchange in position 3 and
4, respectively (hereafter referred to as E*-boxes). 16% of the CRBS contained the
motifs CAGGTG and CACCTG, with a double-guanine or double-cytosine in positions
3 and 4 (hereafter referred to as E-GG-boxes). There was no significant fraction of
binding sites with a mismatch in any other position. Of note, only 43% of the CRBSs
featured any of the three E-box-motifs at all, but some sites possessed several motifs.
Interestingly, these three motifs were differently distributed among BMAL1, CLOCK,
and CRY1 binding sites. Table 3.2 shows that 28% of each, BMAL1 and CLOCK
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Table 3.2.: Fraction of binding sites (in %) that harbor an E-box, E*-box or E-GG-box.
E-box type BMAL1 CLOCK CRY1
E-box (CACGTG) 28.5% 28.1% 8.3%
E*-box (CATGTG/CACATG) 20.7% 25.7% 20.7%
E-GG-box (CAGGTG/CACCTG) 17.9% 17.3% 11.6%
CRBSs harbored an E-box, whereas 21% and 26%, respectively, contained an E*-box.
About 18% of both possessed the E-GG-box. At the same time only 8% of the CRY1
binding sites harbored a perfect E-box, whereas 21% contained an E*-box and 12%
an E-GG-box. The relative amount of E*-boxes in CRY1 sites was thus the same as in
BMAL1 and CLOCK sites, whereas E-GG-boxes were present slightly less.
Figure 3.5 (bottom panel right) shows, that CRY1-only CRBSs harbored less E*-
boxes (14%) than CRY1 sites overlapping with BMAL1 and/or CLOCK, but that the
canonical E-box was virtually absent (4%). E-GG-boxes, however, were equally present
in all CRY1-sites (11%).
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Figure 3.6.: Binding sites harboring a perfect E-box were strongly enriched around
the TSS. Histogram of CRBSs containing only the canonical E-box motif
(top left), the E*-box (top right), or the E-GG-box motif (bottom left) or
none of these (bottom right). The distance was calculated in 2 kb-bins.
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Of interest, CRBSs that only contained the perfect E-box motif were highly enriched
around the TSS of genes, whereas binding sites that either only harbored the E*-box or
the E-GG-box motif, were not enriched around the TSS and were distributed like sites
not containing any of these motifs at all (Figure 3.6).
Similar to the published data in mouse [5], auto correlation analysis on the CRBSs
from this work found the highest probability for a repeating tandem E-box sequence at
a spacer of 6 nucleotides (Figure 3.7, left-hand side). The average sequence logo for
tandem E-boxes with zero to three mismatches was computed and the total number of
tandem motifs was plotted (Figure 3.7, right-hand side).
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Figure 3.7.: Occurrence of tandem E-box motifs in CRBSs. Auto-correlation showed
an enrichment of tandem E-boxes with a spacer of 6 bp. The optimal
spacer length was calculated by shifting the entire sequence step by step
by one nucleotide (upper left panel). The fit between the original E-box
(black) and the next E-box was calculated by auto-correlation. To control
for sequence composition bias the sequences were randomly shuffled
and analyzed again (grey). The sequence logo for the best-fitting E-
box motif with ≤ 3 mismatches is shown in the upper right panel. The
lower right panel shows the total number of tandem E-boxes found in the
CRBSs.
There were only few tandem motifs with no (5) or one (45) mismatch, but there
were 156 tandem motifs with two mismatches and 588 with three mismatches. Some
CRBSs featured multiple tandem E-box motifs, overall yielding 555 (18.2%) CRBSs
with at least one tandem motif with up to three mismatches. This is >5-fold above what
would be expected in a random data set. The core clock genes DBP, DEC1, DEC2,
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PER3, and TEF had one binding site each which harbored a tandem E-box with three
mismatches, the other core clock genes did not contain a tandem E-box in their binding
sites at all.
CRY -genes have been reported to bind to glucocorticoid receptors and to repress
transcription at glucocorticoid response elements (GREs) in target genes [120]. This
finding cannot be supported by the data at-hand. Analysis of the consensus GRE-
motif in the CRBSs showed that in fact only a small fraction of CRY1-sites contained
a GRE (Figure 3.8) and that there was only a very slight enrichment in comparison to
the randomly shuffled control. A higher fraction of BMAL1 and CLOCK binding sites
harbored a GRE, however, these seem to be sequence biased for the motif, because
in comparison to the randomly shuffled control, again, there is only a slight enrichment
in GREs among the CRBSs.
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Figure 3.8.: There is no enrichment of the GRE-motif in the binding sites. Upper
panel: GRE sequence logo. Lower panel: Fraction of sites harboring a
GRE-motif with 0-3 mismatches (as indicated by the color chart) for all
CRBSs (left), sites found for CRY1-only (center), all BMAL1 and CLOCK
sites (right). To control for sequence bias the sequences of the binding
sites were randomly shuffled and analyzed again (grey bars).
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3.1.6. Binding site clusters
Finally, we observed that the CRBSs were, unlike data obtained from mouse liver,
not evenly distributed over the DNA. Some chromosomes had a substantially higher
amount of binding sites, especially towards the outer regions. Histograms of the
CRBSs show that especially on chromosomes 5, 7, 8, 13, and 14 there appear to be
regions of about 10 Mb with abnormally high densities of binding (Figure 3.9). Since
the work was performed in a tumor cell line, it may be that these regions with clus-
tered binding sites could be a result of amplification of certain areas. Amplified regions
should yield a higher background in ChIP-sequencing because unspecific binding can
occur proportionally more often. Regions with high density of CRBSs were compared
to the remaining portion of the chromosome (Table 3.3) and the difference in back-
ground tags was computed bioinformatically. Only the data from BMAL1 ChIP-seq
was used, because sequencing was deepest there, yielding a higher coverage of the
background. BMAL1-tags were compared to a sequenced sample of 293T HEK DNA,
where no chromosome alterations have been reported. Interestingly, for all tested re-
gions, the enrichment was only 1.5 to maximally 3-fold, which by itself cannot account
for up to 100x more binding sites in these regions. Moreover, a comparison of pure
genomic DNA from U2OS and HEK cells using qPCR on several regions on the chro-
mosome with the highest enrichment, chromosome 7, yielded a similar enrichment of
up to 3-fold (data not shown).
Table 3.3.: Regions with extraordinary high densities of binding sites were found in
U2OS cells. Most of these sites were localized at the outer regions of
chromosomes.
Chromosome Region Localization Enrichment
chr 5 0 - 10 Mb beginning 1.5x
chr 7 0 - 10 Mb beginning 3x
chr 8 140 - 150 Mb end 1.6x
chr 13 110 - 115 Mb end 1.5x
chr 14 60 - 80 Mb centered 1.7x
Histograms of E-boxes in chromosomes 5, 7, 8, 13, and 14 showed, that in many
cases the regions with extremely high amounts of binding sites also contained a higher-
than-average number of E-boxes. It appears possible that the occurrence of slightly
amplified chromosomal regions, in combination with a high amount of E-boxes resulted
in the observed strong clustering of binding. Figure 3.9 displays the histograms of
CRBSs and E-boxes in the chromosomes with extraordinary high binding site densities.
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Figure 3.9.: Clustered binding sites can often be found in regions with high E-box
densities. Histograms for the number of CRBSs (dark grey, left y-axis)
and the number of E-boxes (light grey, right y-axis) were made with a bin
of 2.5 Mb for the chromosomes 5, 7, 8, 13, and 14, where regions with
exceptionally high binding site densities were found. Note that for some
regions no sequence data is available, which is shown by the lack of a
count of E-boxes.
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3.2. Expression analysis revealed about 1% rhythmic
genes in U2OS
Each CRBS identified by ChIP-seq was attributed to the gene with the closest TSS.
By this means 1454 genes with binding sites were identified. Next, we analyzed
whether genes with a binding site show circadian mRNA expression rhythms. Two
microarray-experiments were performed with RNA from the time courses Z4 and Z5
in temperature-entrained U2OS cells that were harvested every three hours over two
consecutive days.
A custom-made 60k-microarray was designed (see Methods). The probes were spe-
cific for 1373 genes found closest to a ChIP-seq binding site. For control, two sets of
genes without binding sites were tested. One set contained 3480 completely random
genes, whereas the other set consisted of 1503 specifically selected potentially rhyth-
mic genes. Among these were 443 genes from ChIP-sequencing that were not the
closest gene to a binding site but nevertheless harbored a CRBS within ± 20 kb of
their TSS. 1285 genes with CRBSs (93.6%), 3059 random genes (87.9%) and 1364
(90.8 %) of the group of selected genes without CRBSs were expressed.
For data analysis three main criteria from chronobiology were used to define rhythmic
genes: a 24h-oscillation, amplitude and phase (Figure 3.10).
12h 24h 36h 48h0h
Expression
signal
Figure 3.10.: Simplified overview over the main criteria used to define rhythmicity.
The rhythm of expression can be approximated by fitting a cosine-curve
with a 24h-period to the data points. The amplitude of gene expression
is depicted by the black arrow and marks the influence of the circadian
clock on expression of that particular gene. The phase is determined
by the first maximum of the fitted cosine-curve (blue arrow represents
phase ZT 12, red arrow represents phase ZT 23).
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The first criterion is a prerequisite for rhythmicity, because a clock-controlled gene
should oscillate with a period of about 24 hours. For this, the Fisher test was used as
described [5, 197]. Roughly, this mathematical method describes how well the data
fits a cosine curve. The curve was defined to contain a 24-hour component for the 24-
hour rhythmicity, as well as a 48-hour component, which would allow to fit a dampening
curve. The other two criteria define the rhythmicity more precisely. The amplitude pro-
vides information on how strongly a gene is regulated by the circadian clock. In this
work it is defined as one half of the value between the peak and the trough of the fitted
cosine curve, if not specified otherwise. The phase is set in relation to a Zeitgeber and
enables a comparison of the time point of expression between two or more genes. In
this work, the phase is defined as the first peak in expression 24h after release to 37°C.
Rhythmic genes were defined applying a set of stringent criteria, which reflect these
key factors and their comparability between two independent data-sets (see methods
for more detail). Thus, a set of 118 oscillating genes was identified, 58 with a CRBS,
and 60 genes without (Figure 3.11).
Time (CT)
0 12 24 36
genes with CRBS (n = 58)
max
min
Time (CT)
0 12 24 36
genes without CRBS (n = 60)
Figure 3.11.: Heatmap view of the 24h cycling genes from the microarray ordered by
phase of expression. The median expression level of each time point
is shown in relation to the mean of all time points (upregulation: yellow,
downregulation: blue). The left panel represents rhythmic genes with
an assigned binding site, the left panel circadian genes without a CRBS.
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Among the rhythmic genes with a CRBS were the core clock genes CRY1, CRY2,
DBP, DEC1, DEC2, PER1, PER2, PER3, REVERBα, REVERBβ and TEF, which are
known to be regulated by BMAL1/CLOCK. In the group of oscillating genes without
binding sites were, as expected, BMAL1, E4BP4 and NPAS2. Thus, virtually all core
clock genes were identified, indicating that the expression analysis was suitable for the
detection of circadian genes.
A plot of the amplitude versus the circadian phase color-coded by the degree of
rhythmicity revealed a biphasic profile of expression with two peaks around CT 15 and
CT 3 (Figure 3.12 top panel) for highly rhythmic genes. The expression of circadian
genes without CRBSs was enriched in two sharp peaks at CT 15 and CT 3, whereas
the phases of rhythmic genes with CRBSs peaked at CT15 and to a larger extent at
CT21 - CT6. The latter peak contained all core clock genes that are known to be
controlled by BMAL1/CLOCK (Figure 3.12 middle and bottom panel). Examples for
rhythmic and non-rhythmic genes are shown in Figure 3.13.
The microarray data permits a comparison between genes with and without a CRBS.
4.2% (58 of 1373) of the genes with a binding site were rhythmic. In contrast, only
0.9% (33 of 3480) of the set of randomly chosen genes were expressed in a circadian
fashion. Considering this fraction as the rate by which genes become rhythmic in
an indirect manner, it can be estimated that about 12 of the 58 genes with a CRBS
oscillated for reasons other than their binding site. The remaining 27 rhythmic genes
are from the group of specifically selected genes without a BMAL1-binding site like
BMAL1 and E4BP4, and other potentially rhythmic genes. Of note, from the 443 genes
that did have a CRBS within ± 20 kb of their TSS, but were not the closest to a binding
sites, only 4 genes (0.9%) were rhythmic. Therefore these genes were not more often
rhythmic than the random genes. If a gene contained at least one binding site close
to the TSS (within ± 1 kb) there was an 8-fold higher probability for the gene to be
rhythmically expressed as compared to the random genes, whereas genes with only
distant binding sites (> 1 kb of the TSS) had a 3-fold higher probability (Figure 3.14).
E-boxes and E*-boxes in the CRBS were, although enriched in general, similarly
present in rhythmic and non-rhythmic genes. Out of the 1373 genes with a CRBS
791 (58%) possessed at least one binding site with an E- or E*-box. From the 58
rhythmically expressed genes with CRBSs, a similar fraction, 36 genes (62%), featured
an E- or E*-box in at least one site. About 5% of the genes with an E-box (30 of 571)
or E’-box (21 of 431) containing CRBS were expressed in a circadian fashion.
3.2 Expression analysis revealed about 1% rhythmic genes in U2OS 77
______
____ Rhythmic
Arrhythmic
REVERBβ
BMAL1
DBP
NPAS2
PER1
E4BP4
REVERBαTEF
PER3PER2
CRY2
CRY1
DEC1 DEC2
0
5
10
15
with CRBS
no CRBS
9
Phase (CT)
Am
plit
ud
e
12 15 18 21 0 3 6 9
2.5
2.0
1.5
1.0
0.5
0.0
9
Phase (CT)
Am
plit
ud
e
12 15 18 21 0 3 6 9
2.5
2.0
1.5
1.0
0.5
0.0
9
Phase (CT)
12 15 18 21 0 3 6 9
with CRBS
no CRBS
Fra
ctio
n o
f g
en
es
 (%
)
Figure 3.12.: Rhythmic genes show a tendency to cluster in two phases. Analysis
of temporal expression profiles of 5708 expressed genes in two mi-
croarray replicates identified 118 common genes with diurnal expres-
sion rhythms. Data from time course Z5 is shown. Top: The amplitudes
of expressed genes were plotted versus the circadian phase. The 118
rhythmic genes are indicated by black symbols. The shade of blue cor-
responds to the rhythmicity of a gene (light blue = low 24 h-rhythmicity
and/or phase undefined; dark blue = high 24 h-rhythmicity and reliable
phase). Middle: The amplitudes of the 118 rhythmic genes are plot-
ted against the phase. Genes with CRBSs are shown with black dia-
monds, the other rhythmic genes with gray diamonds. Core circadian
clock genes are indicated. Bottom: Phase distribution of rhythmic genes
with and without CRBSs.
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Figure 3.13.: Examples for microarray time course data from temperature-entrained
U2OS cells. RNA levels of U2OS cells were analyzed in 3 h intervals
over a period of two days. Expression ratios of each time point (0 - 45
h) relative to the average were calculated and plotted on a log2 scale
versus the time (h). For each gene up to 10 probes were spotted on the
arrays, represented by light blue lines. The black triangles and the fitted
dark blue sine curve correspond to the median of the data. Light and
dark areas in the background indicate subjective day and night, respec-
tively. (A) Clock genes with CRBSs. (B) Clock-genes without CRBSs.
(C) Rhythmic genes with CRBSs. (D) Rhythmic genes without CRBSs.
(E) Genes not expressed in a rhythmic fashion. AGAP11 harbors a
highly enriched binding site for BMAL1, CLOCK, and CRY1, CHP has
a CRY1 binding site. In both genes the CRBSs were close to the TSS.
CSNK2B and KDELR1 do not have a CRBS in a window of ± 20 kb.
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Figure 3.14.: Impact of the presence of a CRBS on rhythmicity. Fractions of rhythmic
genes without CRBSs (light grey) and genes with a CRBS (dark grey)
located distant (n = 1021) and close (n = 352) to the TSS (within ±1
kb).
3.3. Genes with a binding site have the potential to be
rhythmic
Among the oscillating genes, core clock genes were generally expressed with con-
siderably higher amplitude rhythms than other clock-controlled genes. The majority
of genes with CRBSs was not expressed in a circadian fashion, not even genes with
high-scoring CRBSs in their promoters, such as ATG3, EIF5A2, or SCN5A. This is in
contrast to mouse liver, where nearly all strongest binding sites were linked to rhythmic
transcript expression [5]. Closer inspection of the microarray data revealed, that some
genes might have been oscillating with a too low amplitude to be detected by the ap-
plied criteria, excluding possibly rhythmic genes like CLOCK (Figure 3.13 B), EIF5A2,
and SCN5A (Figure 3.17 A). The gene ATG3 did not appear to be expressed in a rhyth-
mic fashion at all (Figure 3.17 A). If transcription is controlled by the circadian clock, but
for example the half-life of an mRNA is very long, it is possible, that the preRNA of a
gene is rhythmic, whereas the processed mRNA is not. The probes on the microarray
were designed to detect mature mRNA only, therefore the expression of the pre-RNA
of some of the arrhythmic genes from the array was tested using qPCR on the same
time course that were used for the arrays. However, although the preRNA of BMAL1
was circadian, the preRNAs of the tested genes were not more rhythmic than before
(Figure 3.15).
In order to gain more insights into this phenomenon U2OS cell lines were gener-
ated, that expressed the destabilized luc2P under control of the promoters (about -1
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Figure 3.15.: The preRNA levels of ATG3, EIF5A2, and SCN5A are not rhythmic.
PreRNA-expression BMAL1, ATG3, EIF5A2, and SCN5A was tested
using qPCR on the two time courses (Z4 and Z5) that were assayed
on the microarray. The data of each time course was normalized to the
mean.
kb to the TSS) of these genes. Of each cell line, more than one single cell clone was
obtained and expression of luciferase was monitored over several days and compared
to similarly obtained controls with known clock-controlled promoters, i.e. CRY1-luc2,
PER2-luc2, and NR1D1-luc2 and the previously published cell line U2OS BMAL1-luc
[4], as well as a negative control cell line with luc2P under control of the GAPDH-
promoter. The data was detrended using the MultiCycle software (Actimetrics).
Interestingly, the tested promoter-luciferase constructs ATG3-luc2P, EIF5A2-luc2P,
and SCN5A-luc2P yielded a solid, reproducible circadian rhythm, even though the
genes themselves were not expressed in a diurnal fashion on the microarray. The
expression of luciferase was in a different phase than expression of luciferase regu-
lated by the BMAL1-promoter. Control luc2-expressing cell lines with the promoters of
the known core-clock genes CRY1, PER2, and NR1D1, showed a robust luciferase-
oscillation in a similar phase to the tested constructs. Luc2P under the control of the
GAPDH-promoter, did not exhibit a circadian rhythm (Figure 3.16).
The raw data from the promoter-luciferase constructs (Figure 3.17 B bottom vs.
top) shows that despite the use of the unstable luc2P reporter, the amplitudes (peak
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Figure 3.16.: Promoter-luc2P constructs of genes with a CRBS are rhythmic. U2OS
promoter-luciferase cell lines were generated that stably expressed
constructs, in which the destabilized luc2P was under control of pro-
moters of the three non-rhythmic genes ATG3, EIF5A2, and SCN5A,
that harbor a CRBS in this region. Luc2 regulated by the promoter of
three core-clock genes was used as positive control, while GAPDH-
luc2P served as a negative control (upper panel). The NR1D1-luc2
data is from a pool of cells after selection. For all other constructs sev-
eral single cell clones were selected and measured at 37°C for 6 days
at 30 min intervals. Data was detrended using the Multicycle software.
The data from several wells for one single cell clone is shown (grey), as
well as the average of all wells (black). The pink line marks the expres-
sion of BMAL1-luc when measured in the same experiment. Note that
the scale is different for the top row and the bottom row.
- trough) of the ATG3, EIF5A2, and SCN5A-promoter controlled rhythms were low
in comparison to their Luc2P mean expression levels. Baseline expression of these
genes is probably high, masking a circadian rhythm in vivo. For BMAL1-luc and PER2-
luc2 both, raw and detrended data looked very much alike because the amplitude
was high in comparison to the basal expression of the luciferase (Figure 3.17 bottom).
Baseline expression of these genes is probably mainly controlled by the circadian acti-
vation of transcription. In vivo this discrepancy between BMAL1 and PER2 expression
on one side and ATG3, EIF5A2, and SCN5A expression must even be stronger, since
a more stable form of luciferase was used in BMAL1-luc and PER2-luc2-cells.
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Figure 3.17.: Rhythmic transcription of genes with CRBSs in their promoter is
masked by a high baseline expression. (A) Temporal expression profiles
of ATG3, EIF5A2, and SCN5A. The rhythmic genes BMAL1 and PER2
and the housekeeping gene GAPDH are shown for control. (B) Low am-
plitude transcription rhythms are revealed by long-term luminescence
measurements of stable U2OS cell lines expressing the destabilized
luciferase2P (luc2P) under control of the promoters of ATG3, EIF5A2,
and SCN5A. BMAL1-luc, PER2-luc2, and GAPDH-luc2P cell lines are
shown for control. Luminescence of synchronized cultures was mea-
sured at 30 min intervals. Examples for detrended data (top) and raw
data (bottom) for day 1 to day 5 after synchronization are shown. Sev-
eral single cell clones were obtained showing the same behavior. (C)
Contribution of circadian oscillations to the expression levels of these
genes. The grey columns correspond to amplitude (peak - trough) of
the oscillation of the first day. The black columns set the amplitude in
relation to the mean expression levels of day 1 through day 3.
4. Discussion
4.1. BMAL1 and CLOCK CRBSs harbor binding motifs
distinct from CRY1-sites
Most genome-wide studies in mammals to date have been performed in mice. This
work provides insights into the circadian network in humans by means of a rhythmic
human osteosarcoma cell line, U2OS. Recent publications visualized rhythmic binding
of BMAL1 and CLOCK to DNA by ChIP-seq using several time points around the clock
in mouse liver explants [6, 5]. This strongly rhythmic organ is known to exhibit high
amplitude mRNA oscillations, whereas a former expression array study with U2OS
cells yielded only low amplitude mRNA rhythms [3]. Therefore, in this work ChIP-Seq
was performed in unsynchronized U2OS cells. Three individual ChIPs with antibodies
directed against BMAL1, CLOCK, and CRY1, were analyzed by deep sequencing, and
3040 circadian regulator binding sites for all three proteins, comparable to the number
found in highly rhythmic tissues like liver [5], were detected. The known clock-controlled
genes CRY1, CRY2, DBP, DEC1, DEC2, PER1, PER2, PER3, NR1D1, NR1D2, and
TEF possessed 1-4 binding sites each and all of them had at least one common site
for BMAL1 and CLOCK binding, in most cases even for CRY1 as well.
Out of the set of 3040 CRBSs only about 13% overlapped between BMAL1 and
CLOCK, and/or CRY1. This overlap is likely somewhat higher, because some weak
peaks might have been below the identification threshold used in the bioinformati-
cal analysis. Half of the CLOCK binding sites overlapped with BMAL1 binding sites,
whereas only one fifth of BMAL1 binding sites overlapped with CLOCK. This is surpris-
ing, taking into consideration that BMAL1 and CLOCK form a heterodimer that binds
to E-boxes. An explanation for this could be that the BMAL1-ChIP yielded data with a
better signal-to-background ratio, allowing more peaks to be detected. This could be
in part due to technical reasons, such as the sensitivity of the antibody and the fact
that three lanes of the BMAL1-ChIP were sequenced and compared to one lane of the
CLOCK-ChIP. Another possibility could be that NPAS2, which is highly related in amino
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acid sequence to CLOCK and is known to be able to substitute CLOCK function in the
mammalian forebrain [90], binds to BMAL1 in U2OS cells, thereby reducing the total
signal that can be obtained by the CLOCK antibody. The microarray data from this
work indicates that NPAS2-mRNA is expressed in similar levels as CLOCK.
Binding sites for both, BMAL1 and CLOCK, were enriched around transcription start
sites, as would be expected for a transcription factor. However, binding sites for CRY1
were not enriched around the TSS. CRY1 exerts its function in the negative feedback
loop of the clock by binding to BMAL1 and CLOCK [99, 100] and therefore might only
interact indirectly with DNA. Depending on the state of the chromatin, it could be pos-
sible, that during the cross-linking process for the ChIP CRY1 that bound to BMAL1
and CLOCK was crosslinked to other sterically close DNA regions as well, which could
account for a portion of the binding sites that was not enriched around the transcription
start site. This is supported by the fact that a perfect E-box, CACGTG, was found only
in 8% of the CRY1 binding sites, whereas it was found in 28% of each, BMAL1 and
CLOCK binding sites. Interestingly though, a second E-box motif with a mismatch in
the middle positions, CATGTG and CACATG, which was called E*-box motif in this
work, was found to be similarly present in all three ChIPs with 21% occurrence in both,
BMAL1 and CRY1 binding sites, and 26% in CLOCK binding sites. Another motif, with
a -GG- or a -CC- in the middle-positions, called E-GG-box here, was found to be en-
riched in all binding sites as well. This motif was more present in BMAL1 and CLOCK
binding sites (18% each) than in CRY1 binding sites (12%), but the difference was not
as pronounced as for perfect E-boxes. The E*-box motif was described recently as part
of a possible 7-bp noncanonical binding motif for BMAL1 and CLOCK [166], supporting
the notion of its special importance. However, no preference for the base following the
E*-box motif was found in this work. Moreover, there was no enrichment for the E’-
box motif ((T)CACGTT), which was described to be important for mPer2-transcription
[166, 167].
Our data shows that binding sites containing the E*-box or the E-GG-box motif were
only weakly enriched around the TSS and displayed a behavior similar to CRY1-binding
sites. This suggests that there might exist at least two different classes of binding
sites. One class harbors perfect E-boxes and is found preferentially in the vicinity of
transcription start sites, whereas the other class contains E*-boxes or E-GG-boxes and
is distributed randomly. Perhaps the binding to a perfect E-box results in a conformation
of the BMAL1-CLOCK heterodimer that reduces the ability of CRY1 to interact with
BMAL1-CLOCK. Alternatively, it may not be the CRY1-binding that is affected, but only
the ability to immunoprecipitate CRY1 at BMAL1-CLOCK sites with perfect E-boxes. If,
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for instance, CRY1 were able to release BMAL1 and CLOCK from the DNA efficiently at
sites with perfect E-boxes, but only slowly at noncanonincal E-boxes, then there would
be a higher probability to immunoprecipitate CRY1 at these sites. In any case CRBSs
with E*-boxes appear to be functionally distinct from sites harboring perfect E-boxes.
The relatively high occurrence of the E*-box motif in CRY1 binding sites that do not
overlap with BMAL1 and CLOCK suggests that there also might be another binding
partner for CRY1, possibly a different bHLH-transcription factor. Crystal structure anal-
ysis of the BMAL1-CLOCK heterodimer indicates that CRY1 binds the complex via
CLOCK [100]. It therefore seems likely that BMAL1 could be substituted by another
bHLH-protein. Most bHLH transcription factors bind to E-box motifs, but they show dif-
ferent specificities as to the exact sequence of the motif [163]. CLOCK can form func-
tional dimers with the BMAL1 paralog, BMAL2 [93, 199], which is not recognized by
the BMAL1-antibody used in this work [5]. Not enough is known about BMAL2-CLOCK
binding sites to tell, whether they possess a different sequence specificity. Another
protein, which was found to preferably bind to the E*-box motif is the MYCN protein
[200]. Although nothing is published about its possible binding to CLOCK or CRY1,
this sequence specificity for E*-boxes makes it an interesting candidate for interactions
with CRY1, even more so since MYC proteins are often overexpressed in tumor cells.
It has previously been shown, that CRY1 can bind to glucocorticoid-receptors, which
then bind to GREs on the DNA [120]. However this work cannot support this finding
because no considerable enrichment for GREs was found among the binding sites.
It is to be noted, that the E-box motif, even when allowing one mismatch, was found
in only 65% of the binding sites, which is along the lines of what has been found in
other studies as well [5, 6]. Two thirds of these sites contained a perfect E-box, an E*-
box, or the E-GG-box motif. Although there was little or no enrichment of other E-boxes
with one mismatch among the binding sites, they still occurred with a certain frequency,
making up the other third of sites with E-box motifs. The occurrence of E-boxes alone
does not appear to be able to explain the binding of BMAL1 and CLOCK. In fact, even
the known clock-controlled gene CRY1, did not contain an E-box or E*-box sequence
in or near the CRBS that was found. It did harbor the already mentioned CACGTT
motif, which was not enriched among the binding sites.
Tandem E-boxes with a spacer of 6 nucleotides have been found to be required for
rhythmic expression of genes [165]. A tandem E-box motif with up to three mismatches
and a spacer of 6 nucleotides was present in 18% (555 of 3040) of the binding sites,
corresponding to 385 of 1454 (26%) genes in the dataset at-hand. The notion, that
tandem E-boxes are required for rhythmic expression can, however, not be fully sup-
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ported through this work. Only the clock genes DBP, DEC1, DEC2, PER3, and TEF
possessed binding sites with a tandem E-box with three mismatches, the other core
clock genes didn’t contain a tandem E-box at all in their binding sites. Overall, a tan-
dem E-box (with 2 or 3 mismatches) was present in 31% (18 of 58) of rhythmically
transcribed genes with a CRBS, marking only a slight increase of this motif among the
oscillating genes.
In the data set a clustering of binding sites was detected mostly at the outer 10 Mb
of chromosomes 5, 7, 8, 13, and 14. These five regions, which amount to an overall
size of about 50 Mb, account for about 1/3 of the detected CRBSs. This work was per-
formed in a tumor cell line with an average of 76 chromosomes. Therefore, it seems
likely that a special amplification of these chromosomal regions could have lead to a
higher background signal, yielding an increased false discovery rate of binding sites.
Further analysis though showed that these regions were not present in significantly
higher copy numbers than the rest of the chromosome. In most cases a 1.5-fold en-
richment of these regions was detected, which could result from a single crossing-over
event at the outer regions, eventually leading to one more copy of this region in U2OS
cells compared to the average amount. This by itself however, does not seem to be
able to account for the massive overrepresentation of binding sites from these regions
in the data set. Finally, it was also observed, that these regions often contained a
high amount of E-boxes, which probably contributed partially to the large number of
detected CRBSs. Therefore these clustered regions were not regarded separately in
the entire analysis. Moreover, these binding sites contributed only to a relatively small
number of genes, some of which were found to be expressed in a circadian manner.
4.2. A small fraction of genes with a CRBS is rhythmic
Rhythmicity of genes in U2OS cells was analyzed by applying an RNA-time course of
temperature-entrained U2OS cells on a custom-made microarray. Using stringent crite-
ria, a subset of 118 genes was defined as rhythmic and 58 of these harbored a CRBS.
Among these were most of the known clock-controlled genes. The fraction of random
oscillating genes was 0.9%. The set of genes that were within ± 20 kb of a TSS,
but not the closest gene to a binding site, was equally often rhythmic as the random
genes. In general, genes with a CRBS close to the TSS were considerably more often
circadianly expressed. By extrapolation, it can be estimated that about 200-300 of all
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transcribed genes are rhythmically expressed in U2OS cells, but probably only 46-58
genes are controlled directly by BMAL1 and CLOCK. This is higher than the 7 rhythmic
genes reported before for U2OS cells [3], but nonetheless it is about 10-fold lower than
the number found in mouse [1, 3, 5, 6]. Genes with BMAL1-only or CLOCK-only sites
were not more often rhythmic than genes with a CRY1-only binding site. About 3-3.5%
of the genes with a single CRBS were rhythmically expressed on the microarray. The
values were similar for common BMAL1-CRY1 binding sites, whereas no genes with
sites for CLOCK-CRY1 binding became rhythmic, but it must be noted that the num-
bers for these common CRBSs were very low. A significantly higher fraction of genes
was rhythmically expressed, when a BMAL1-CLOCK (9%) or a BMAL1-CLOCK-CRY1
(10%) binding site was found. This shows, that common BMAL1-CLOCK CRBSs, es-
pecially within ± 1 kb of a TSS, had a certain predictive power, whereas single binding
sites did not. This must be noted with caution, though, due to the overall small number
of circadian genes with CRBSs.
The expression of rhythmic genes with a binding site clustered in two phases which
were about 12 hours apart. 43 genes were expressed in phase with known BMAL1-
CLOCK controlled genes of the core-clock like the PER, CRY and REVERB-genes,
whereas 15 genes were expressed in phase with REVERBα regulated genes like
BMAL1 and NPAS2. The latter genes harbored only single binding sites with a low
global score, that reflects the quality of the binding site and it seems likely that a sub-
stantial portion of these were rhythmic due to other reasons than their binding sites,
which would be in accordance with the false positive rate of 0.9%.
All known core-clock genes with the exception of the ROR genes were rhythmic and
expressed as reported before: The CLOCK gene showed only a weak rhythmicity and
was not among the selected 118 rhythmic genes, which is in accordance with reports
in the literature, attributing varying degrees of rhythmicity to CLOCK expression in dif-
ferent tissues of mice [1]. The gene for the bZIP-protein E4BP4, a transcription factor
that counteracts the function of DBP and TEF, was expressed in antiphase to their
mRNA [137]. CRY1 has been reported to be expressed extremely late [201] and with
a phase-delay relative to NR1D1 [132]. This is reflected in the microarray data where
the REVERB-genes are the earliest core-clock gene to be expressed, whereas CRY1
is the latest core-clock gene in the defined phase-window. These correlations to the
literature demonstrate the high quality of the time course data and increase reliability
of the so far unknown data.
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4.3. Functional classes of rhythmic genes in U2OS
The proteins encoded by most of the newly identified directly-controlled rhythmic genes
have important roles in cellular function, such as glycogen synthesis (PPP1R3B,
GYG1), siRNA-induced gene silencing (EIF2C1), cell-cell-interaction (COL22A1,
COL17A1), transport of molecules or ions (ABCG1, ANO2), and nucleotide-synthesis
(MTHFD1L). Among the rhythmic genes there are also many regulatory genes with the
potential to control another subset of genes on a second level of hierarchy, such as
genes involved in stress response (GADD45B), signal transduction (PRKCH, PREX1,
RALGDS, SULF2) and regulation of transcription, which is the largest class of oscillat-
ing genes. Rhythmically expressed transcription factors such as the genes for AFF3,
CCDC85B, FOXJ2, KLF11, and TFEB each have different groups of target genes,
which thus may be indirectly regulated by the circadian clock.
Among the circadianly expressed genes without a CRBS transcriptional regulators
apart from the core-clock genes BMAL1, NPAS2, and E4BP4, were less prominent, but
for a couple of examples (HMGA2, TSC22D3, ZNF323). The protein products encoded
by many of the oscillating genes without CRBSs are involved in important processes in
the cell, such as glucose and fatty acid metabolism (ACAD, H6PD, PYGL) and signal
transduction (CAMK2D, FGFR1, NRG1, PDE4B, PPP3CA, TNFSF15, WNT5B). More-
over, some proteins are important in the cytoskeleton and cell adhesion (LIMS2, NRG1,
PALLD), in the extracellular matrix (MMP3, MMP24, SUN3), the oxidative stress re-
sponse (AOX1, OSGIN1), RNA-binding (HNRPDL), and transport and channels
(ATP1B1, CLTCL1, SLC2A1).
Interestingly, there are several examples for rhythmic genes that are involved in the
same pathway. The SERPINE1 (Serpin Peptidase Inhibitor) gene, which harbored
three BMAL1-binding sites close to its transcription start site, and the genes PLAT (Tis-
sue Plasminogen Activator) and PLAU (Plasminogen Activator), the proteins of which
are also known as tPA and Urokinase, respectively, which did not have any binding
sites, are all classically involved in the fibrinolysis pathway, regulating the turn-over
of blood-clots. SERPINE1 is the principal inhibitor of tPA and Urokinase, which both
can cleave Plasminogen in order to give rise to the active fibrinolytic protease Plas-
min. In mouse SCN, there are several reports showing that Serpine1 is rhythmically
expressed [1, 202] and diverse reports about the expression of the gene Plat, which
was rhythmic and in the same phase as Serpine1 in one report [1], but constantly ex-
pressed in another [202]. Moreover, comparison of SCN of wild-type, Clock-mutant,
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and Cry1/Cry2-deficient mice has shown that expression of mouse Serpine appears to
be regulated directly by the circadian clock. This work can substantiate this notion in
a human cell line through the finding of BMAL1 binding sites in the promoter of SER-
PINE1. Moreover, in U2OS cells, not only mRNA expression of SERPINE1, but also of
PLAT and PLAU are circadian. SERPINE1 expression peaked at CT 23 together with
the early core-clock genes like NR1D2, which was in a different phase to expression of
PLAT and PLAU, that both peaked at CT 15. The latter ones appear to be regulated
on a second-level of hierarchy. A tempting speculation would be that there is some
regulation, that purposefully enables expression of these genes in different phases in
order to separate expression of the proteases from their inhibitor, thus allowing a tem-
poral window in which the proteases can function. It would be interesting to know what
the reason for rhythmic expression of these proteins in U2OS cells is. One publication
suggests a function of plasmin which is not related to fibrinolysis, but to regulation of
the protein BDNF (Brain-Derived Neurotrophic Factor) which has been shown to be
able to modulate light- and glutamate-induced resetting of the clock in the SCN [203].
This hints to a new function of the plasmin-system in the circadian clock at least in
the brain. On another line of investigation, the expression of tPA and Urokinase was
reported in mouse osteoblasts and osteogenic sarcoma cells of rat origin, where they
were assumed to regulate bone metabolism [204, 205, 206]. It thus appears likely, that
the various processes of bone turn-over could be regulated in a timely manner by the
circadian clock, which is reflected in the bone-derived U2OS cell line.
Another example for such antiphasic behavior of two related proteins is found for
the genes ANO1 and ANO2, which are close members of the Anoctamin family and
are probably Ca2+-activated Cl- channels. ANO2 harbored a CRY1-binding site and
was rhythmic with a peak at CT2, while ANO1, which did not contain a binding site,
was rhythmic in antiphase to it with a peak at CT18. These two ANO proteins might
have different kinetics through variable gating characteristics. Anoctamins are highly
overexpressed in some cancers. It is assumed that they participate in cell proliferation
or tumor progression, since the activity of several anion channels correlates with the
cell cycle [207]. As to now, there are little studies involving the regulation of channels
by the molecular clock, although many channels and transporters have been found to
be regulated in a circadian fashion in this work.
Two key enzymes of metabolic pathways were among the rhythmic genes without
CRBS: ACADL (Acyl-Coa Dehydrogenase) and H6PD (Hexose-6-phosphate Dehydro-
genase). ACADL is one of the four enzymes that catalyze the initial step of mito-
chondrial beta-oxidation of straight-chain fatty acids and therefore is important for en-
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ergy generation. H6PD is the rate-limiting enzyme in the pentose phosphate pathway,
a metabolic pathway that increases cellular levels of the co-enzyme NADPH (nicoti-
namide adenine dinucleotide phosphate). Fatty acid biosynthesis consumes NADPH
and thereby increases the cellular level of NADP+, thus stimulating H6PD to pro-
duce more NADPH. In this respect these two enzymes function in opposing pathways,
ACADL in fatty acid oxidation and G6PD in fatty acid biosynthesis. This may be re-
flected in their circadian expression pattern that is also in antiphase to one another,
with ACADL being expressed at CT 5 and H6PD peak expression at CT 17.
An important link between circadian clocks and metabolism has been established
in recent years based on the family of the peroxisome proliferator-activated recep-
tors (PPAR). Although ChIP-seq identified a BMAL1-CRY1 binding site in an intron
of PPARA, it was not among the 118 rhythmic genes from the microarray. Neverthe-
less, two other genes from the PPAR-family were rhythmic in U2OS-cells even with no
CRBS, PPARG and the coactivator of PPARα, PGC1A. PPARG peaks at CT4, whereas
PGC1A peaks at CT16. SIRT1 was found to regulate transcription of PGC1A, which
then stimulates the expression of clock genes, especially BMAL1 and NR1D1 through
coactivation of the ROR family of orphan nuclear receptors [132]. PPARγ induces ex-
pression of Nr1d1 in adipose tissue of mice [130].
These examples illustrate that there are multiple ways how the relatively small set of
rhythmic genes could influence the cell in a global way. Not only transcription factors,
but also ion channels and key enzymes in signal transduction and metabolic pathways
were found to be rhythmic. Circadian expression of genes without CRBSs could be
regulated on a second level of hierarchy by the directly clock controlled genes, for
example via rhythmically expressed transcription factors, or through a feedback of a
rhythmic cellular state, e.g. the metabolism, on gene expression.
4.4. Rhythmic transcription of genes with CRBSs can
be masked by a high baseline expression.
96% of the genes with a CRBS were not found to be rhythmic. A certain portion,
but not all of them, might have been oscillating with a very low amplitude that could
not be detected by the applied techniques and criteria. Therefore specific candidate
genes were chosen that did have a binding site in their promoter region, but were not
oscillating on the array. The gene EIF5A2 harbored a common CRBS for all three
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proteins, BMAL1, CLOCK, and CRY1 in its promoter region. Its expression profile
on the microarray displayed a possible low-amplitude rhythm. The gene ATG3, on
the other hand, appeared constitutively expressed on the microarray. It possessed a
common binding site for BMAL1 and CLOCK and was located in a chromosomic region
with high gene density. Although the binding site was only 255 bp upstream of the TSS
of ATG3, it was closer to the TSS of another gene, transcribed on the other strand,
SLC35A5, which was not rhythmic either. Expression levels of ATG3 were high and
similar to those of the highest expressed rhythmic genes. SCN5A harbored two binding
sites for BMAL1 and one for CLOCK. Although none of these genes were rhythmic on
the microarray, all three promoters featured perfect E-boxes within their CRBSs. The
CLOCK site of SCN5A even contained a double E-box motif with a perfect E-box in
tandem with an E-box harboring two mismatches.
Recent work suggested that about 15% of the oscillating genes in mouse liver con-
tained rhythmic introns, which reflected the preRNA levels, whereas their exons did
not cycle detectably [6, 208]. This behavior could result from post-transcriptional reg-
ulation, such as mRNA turnover. A long mRNA half-life leads to an accumulation of
mRNAs that would mask a circadian rhythmicity in gene expression. qPCR analysis of
preRNA in U2OS showed, that although BMAL1 preRNA was rhythmic, the preRNAs
of ATG3, EIF5A2, and SCN5A were not.
U2OS cells stably expressing promoter-luc2P constructs of these genes were rhyth-
mic for many days, displaying a 24h-rhythm in similar phase to constructs of known
clock-controlled genes such as CRY1-luc2 and PER2-luc2. Importantly, the raw-data
showed a 24h-oscillation, overlain by a constitutive high expression. The amplitudes of
the transcription rhythms were rather low in comparison to the mean transcription ac-
tivity of these promoters. This behavior was not found for the BMAL1-luc or PER2-luc2
cell lines, although Luc and Luc2 are more stable than Luc2P. It appears, that there are
two or more components regulating expression of the tested target genes: a rhythmic
24h-component and another component constitutively driving transcription. The com-
bined action of both yields the observed behavior for the tested promoter-luciferase
constructs. Detrending of the data uncoupled the circadian rhythm from other compo-
nents and therefore displayed a clear rhythm. In vivo such a rhythm is probably too
weak to be detected with a 3 h-resolution on a microarray, but can be discerned by
promoter-luciferase constructs where data was collected every 30 minutes.
The examples at hand probably show the superimposed action of at least one other
activating transcription factor, which acts along with BMAL1 and CLOCK, resulting in a
non-rhythmic or weakly rhythmic expression profile. In a cell, there are always several
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transcription factors and modifiers competing for binding sites and acting on transcrip-
tion. Some transcription factors inhibit, others activate gene expression. In the end a
balance is obtained between weak and strong, activating and inhibiting action, yield-
ing a specific expression profile of a gene. Since these factors can be expressed in a
tissue-specific or time-specific manner the expression of a gene can vary greatly be-
tween different tissues. In a different cell type the circadian clock could dominate over
other transcription factors, thus resulting in a more strongly rhythmic expression. Alter-
natively a transcriptional repressor could dominate over the circadian clock, switching
transcription completely off.
SCN5A is a subunit for a sodium-channel, which is found primarily in cardiac muscle.
This channel is responsible for the initial upstroke of the action potential in an electro-
cardiogram. Interestingly, although its mRNA is not rhythmic in U2OS cells, there is
a (yet unpublished) report from another group, that found Scn5a to be rhythmic in the
heart muscle of mice [209]. This gene might be a good example for tissue-specific
regulation. Its potential rhythmicity was acknowledged by its multiple CRBSs and the
promoter-luciferase rhythms, but could only be shown in a tissue where it contains an
important function.
A number of key proteins are rhythmically expressed in a tissue specific manner,
allowing the circadian clock to optimize protein function at specific times of the day,
e.g. metabolic enzymes in liver, bone turnover regulation in osteoblasts, and a sodium-
channel for heart-function in the heart muscle. In most other tissues, however, these
genes might not be expressed in a rhythmic fashion. Mechanisms determining the
cell type specific complexity of circadian transcriptomes are not well understood. This
work shows, that although a similar number of binding sites was found in ChIP-seq
experiments, in U2OS cells only about 200-300 genes are probably rhythmically ex-
pressed, while in mouse liver, up to 3700 transcripts were expressed in a diurnal fash-
ion [5, 6, 3, 210]. How can this finding be explained? A substantial portion of the
3040 CRBSs in U2OS is E-box specific. There could be a functional difference be-
tween CRBSs with canonical E-boxes that are mainly found in the vicinity of TSSs and
CRBSs with E*-boxes that are rather randomly distributed, however no difference in
rhythmicity was observed in this work. Amongst the oscillating genes in U2OS were 14
genes that are part of the core circadian clock machinery. These clock genes displayed
relatively high amplitude expression rhythms (peak to trough ratios of 2 - 4), which
are, however, substantially lower than the expression amplitudes of the corresponding
genes in mouse liver [210]. The amplitudes of the remaining clock-controlled genes
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Figure 4.1.: Model of the effect of overwriting transcription factors.
with and without CRBSs were considerably lower (<1.5-fold). The promoter-luciferase
constructs indicated, that many more genes with a binding site have the potential to be
rhythmically expressed, but that the rhythmic component could be masked by binding
of another transcription factor. We therefore hypothesize that BMAL1 and CLOCK bind
opportunistically to accessible E-boxes in the DNA, but depending on the amount of
other specific transcription factors in the cell, this binding will or will not be translated
into a detectable rhythm of gene expression (Figure 4.1). Tissue-specific transcrip-
tional activators or repressors could bind in the proximity of BMAL1 and CLOCK or
modify the epigenetic landscape around the binding site, thus overriding a circadian
effect or reducing it. Other scenarios are possible, where integration of various signals
would lead to modification of the expression pattern, depending on the state of the cell.
Tissue-specific modifiers would allow for genes to be rhythmic in one cell type, but not
in another, although the same binding site is present in all cells, thus explaining the
finding that the overlap of rhythmic genes between different tissues is very small [1].
This work therefore provides a list of genes that are potentially regulated by the
circadian clock in one or another cell type. It can be used as a starting point for further
work on more specialized pathways or for specific analysis of gene expression in U2OS
cells. Moreover, it provides a model on how tissue-specificity can be obtained with
the same binding site repertoire in different tissues, resulting in flat expression of a
gene in one cell type and rhythmic expression in another. This hypothesis needs to be
substantiated with more in-depth experiments in various tissues in the future.
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